<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="sitemap.xsl"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml"><url><loc>https://www.lifesciencelaw.ch/news/2022-09-16_treatments-and-vaccines-for-covid-19-4</loc><lastmod>2026-10-23T18:03:29+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-16_treatments-and-vaccines-for-covid-19-4" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-16_covid-19-vaccines-authorised-25</loc><lastmod>2026-10-23T18:03:30+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-16_covid-19-vaccines-authorised-25" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-16_covid-19-vaccines-authorised-26</loc><lastmod>2026-10-23T18:03:30+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-16_covid-19-vaccines-authorised-26" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-09_nursing-materials-decisions-on-reimbursements-are-available</loc><lastmod>2026-10-23T18:03:31+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-09_nursing-materials-decisions-on-reimbursements-are-available" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-09_individual-reimbursement-of-medicines-for-children-with-cancer-report-shows-no-unequal-treatment</loc><lastmod>2026-10-23T18:03:32+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-09_individual-reimbursement-of-medicines-for-children-with-cancer-report-shows-no-unequal-treatment" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-09_covid-19-vaccine-nuvaxovid-temporary-authorisation-from-12-years-of-age-and-as-a-booster</loc><lastmod>2026-10-23T18:03:32+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-09_covid-19-vaccine-nuvaxovid-temporary-authorisation-from-12-years-of-age-and-as-a-booster" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-09_new-regulations-on-in-vitro-diagnostic-medical-devices</loc><lastmod>2026-10-23T18:03:33+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-09_new-regulations-on-in-vitro-diagnostic-medical-devices" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-09_swissmedic-journal</loc><lastmod>2026-10-23T18:03:33+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-09_swissmedic-journal" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-09_covid-19-vaccines-authorised-27</loc><lastmod>2026-10-23T18:03:34+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-09_covid-19-vaccines-authorised-27" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-09_ema-press-briefing-on-covid-19-and-monkeypox</loc><lastmod>2026-10-23T18:03:34+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-09_ema-press-briefing-on-covid-19-and-monkeypox" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-09_covid-19-vaccines-recommendations-on-the-use-of-the-authorised-adapted-covid-19-vaccines</loc><lastmod>2026-10-23T18:03:35+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-09_covid-19-vaccines-recommendations-on-the-use-of-the-authorised-adapted-covid-19-vaccines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_protection-of-children-and-adolescents-from-tobacco-advertising</loc><lastmod>2026-10-23T18:03:35+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_protection-of-children-and-adolescents-from-tobacco-advertising" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland</loc><lastmod>2026-10-23T18:03:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update</loc><lastmod>2026-10-23T18:03:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_swissmedic-approves-first-bivalent-covid-19-booster-vaccine-in-switzerland</loc><lastmod>2026-10-23T18:03:37+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_swissmedic-approves-first-bivalent-covid-19-booster-vaccine-in-switzerland" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_report-regarding-suspected-illegal-trading-in-medicinal-products</loc><lastmod>2026-10-23T18:03:37+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_report-regarding-suspected-illegal-trading-in-medicinal-products" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_guidance-document-authorisation-according-to-art-14-para-1-abis-quater-of-the-therapeutic-products-act-tpa-updated</loc><lastmod>2026-10-23T18:03:38+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_guidance-document-authorisation-according-to-art-14-para-1-abis-quater-of-the-therapeutic-products-act-tpa-updated" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_covid-19-treatments-authorised-5</loc><lastmod>2026-10-23T18:03:38+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_covid-19-treatments-authorised-5" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_covid-19-vaccines-authorised-28</loc><lastmod>2026-10-23T18:03:39+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_covid-19-vaccines-authorised-28" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_treatments-and-vaccines-for-covid-19-5</loc><lastmod>2026-10-23T18:03:39+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_treatments-and-vaccines-for-covid-19-5" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_covid-19-vaccines-authorised-29</loc><lastmod>2026-10-23T18:03:40+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_covid-19-vaccines-authorised-29" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_covid-19-vaccines-authorised-30</loc><lastmod>2026-10-23T18:03:40+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_covid-19-vaccines-authorised-30" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_covid-19-vaccines-authorised-31</loc><lastmod>2026-10-23T18:03:40+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_covid-19-vaccines-authorised-31" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-09-02_federal-supreme-court-decision-2c-697-2021-from-28-july-2022</loc><lastmod>2026-10-23T18:03:41+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-09-02_federal-supreme-court-decision-2c-697-2021-from-28-july-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-26_covid-19-current-high-immunity-in-the-population</loc><lastmod>2026-10-23T18:03:43+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-26_covid-19-current-high-immunity-in-the-population" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-26_highly-specialised-medicine-concentration-process-continues</loc><lastmod>2026-10-23T18:03:42+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-26_highly-specialised-medicine-concentration-process-continues" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-26_the-confederation-procures-vaccines-and-medicines-against-monkeypox</loc><lastmod>2026-10-23T18:03:43+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-26_the-confederation-procures-vaccines-and-medicines-against-monkeypox" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-26_important-safety-information-about-xalkori-crizotinib</loc><lastmod>2026-10-23T18:03:44+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-26_important-safety-information-about-xalkori-crizotinib" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-26_foph-corrects-growth-in-health-care-costs-downwards</loc><lastmod>2026-10-23T18:03:44+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-26_foph-corrects-growth-in-health-care-costs-downwards" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-26_questions-and-answers-on-the-medical-use-of-cannabis</loc><lastmod>2026-10-23T18:03:45+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-26_questions-and-answers-on-the-medical-use-of-cannabis" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-26_covid-19-vaccines-authorised-32</loc><lastmod>2026-10-23T18:03:45+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-26_covid-19-vaccines-authorised-32" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-26_covid-19-authorised-authorised</loc><lastmod>2026-10-23T18:03:46+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-26_covid-19-authorised-authorised" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-19_benchmarking-study-2021</loc><lastmod>2026-10-23T18:03:46+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-19_benchmarking-study-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-19_no-free-choice-of-pharmacy-for-new-e-prescriptions</loc><lastmod>2026-10-23T18:03:47+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-19_no-free-choice-of-pharmacy-for-new-e-prescriptions" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-19_position-paper-on-mdcg-documents</loc><lastmod>2026-10-23T18:03:47+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-19_position-paper-on-mdcg-documents" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-19_covid-19-vaccines-under-evaluation</loc><lastmod>2026-10-23T18:03:48+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-19_covid-19-vaccines-under-evaluation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-19_covid-19-vaccines-authorised-33</loc><lastmod>2026-10-23T18:03:49+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-19_covid-19-vaccines-authorised-33" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-19_covid-19-treatments-authorised-6</loc><lastmod>2026-10-23T18:03:48+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-19_covid-19-treatments-authorised-6" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-19_federal-supreme-court-decision-9c-88-2022-from-19-july-2022</loc><lastmod>2026-10-23T18:03:49+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-19_federal-supreme-court-decision-9c-88-2022-from-19-july-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-12_update-on-the-replacement-of-the-register-of-medical-professions-medreg</loc><lastmod>2026-10-23T18:03:50+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-12_update-on-the-replacement-of-the-register-of-medical-professions-medreg" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-12_swissmedic-journal-2</loc><lastmod>2026-10-23T18:03:51+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-12_swissmedic-journal-2" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-12_covid-19-vaccines-authorised-34</loc><lastmod>2026-10-23T18:03:51+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-12_covid-19-vaccines-authorised-34" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-05_application-for-a-coronavirus-vaccine-against-omicron</loc><lastmod>2026-10-23T18:03:52+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-05_application-for-a-coronavirus-vaccine-against-omicron" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-05_covid-19---authorisations-for-the-temporary-import-and-distribution-of-human-medicines</loc><lastmod>2026-10-23T18:03:52+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-05_covid-19---authorisations-for-the-temporary-import-and-distribution-of-human-medicines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-05_temporary-authorisation-to-distribute-in-english-presentation</loc><lastmod>2026-10-23T18:03:53+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-05_temporary-authorisation-to-distribute-in-english-presentation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-05_temporary-authorisation-to-distribute-in-danish-presentation</loc><lastmod>2026-10-23T18:03:53+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-05_temporary-authorisation-to-distribute-in-danish-presentation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-05_authorisation-procedures-for-covid-19-medicinal-products-changes-to-guidance-document</loc><lastmod>2026-10-23T18:03:54+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-05_authorisation-procedures-for-covid-19-medicinal-products-changes-to-guidance-document" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-05_covid-19-vaccines-authorised-35</loc><lastmod>2026-10-23T18:03:54+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-05_covid-19-vaccines-authorised-35" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-05_covid-19-vaccines-authorised-36</loc><lastmod>2026-10-23T18:03:55+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-05_covid-19-vaccines-authorised-36" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-05_covid-19-vaccines-authorised-37</loc><lastmod>2026-10-23T18:03:55+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-05_covid-19-vaccines-authorised-37" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-08-05_covid-19-vaccines-authorised-38</loc><lastmod>2026-10-23T18:03:56+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-08-05_covid-19-vaccines-authorised-38" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-22_international-campaign-against-falsified-and-illegally-imported-medicinal-products</loc><lastmod>2026-10-23T18:03:57+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-22_international-campaign-against-falsified-and-illegally-imported-medicinal-products" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-22_drug-procurement-for-the-treatment-of-covid-19</loc><lastmod>2026-10-23T18:03:56+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-22_drug-procurement-for-the-treatment-of-covid-19" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-22_medtech-europe-survey-report-on-mdr-implementation</loc><lastmod>2026-10-23T18:03:58+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-22_medtech-europe-survey-report-on-mdr-implementation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-22_first-completely-robot-assisted-surgery-performed-in-switzerland</loc><lastmod>2026-10-23T18:03:58+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-22_first-completely-robot-assisted-surgery-performed-in-switzerland" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-22_covid-19-vaccines-authorised-39</loc><lastmod>2026-10-23T18:03:57+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-22_covid-19-vaccines-authorised-39" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-22_covid-19-vaccines-authorised-41</loc><lastmod>2026-10-23T18:03:59+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-22_covid-19-vaccines-authorised-41" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-22_covid-19-vaccines-authorised-40</loc><lastmod>2026-10-23T18:03:59+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-22_covid-19-vaccines-authorised-40" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-22_federal-supreme-court-decision-9c-574-2021-9c-575-2021-from-21-june-2022</loc><lastmod>2026-10-23T18:04:00+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-22_federal-supreme-court-decision-9c-574-2021-9c-575-2021-from-21-june-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-15_covid-19-vaccine-from-novavax</loc><lastmod>2026-10-23T18:04:01+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-15_covid-19-vaccine-from-novavax" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-15_amendments-to-narcotics-ordinances-on-cannabis-for-medical-purposes</loc><lastmod>2026-10-23T18:04:01+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-15_amendments-to-narcotics-ordinances-on-cannabis-for-medical-purposes" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-15_electronic-reporting-of-side-effects-new-online-reporting-form-for-private-individuals</loc><lastmod>2026-10-23T18:04:02+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-15_electronic-reporting-of-side-effects-new-online-reporting-form-for-private-individuals" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-15_ema-safety-updates-for-covid-19-vaccines</loc><lastmod>2026-10-23T18:04:03+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-15_ema-safety-updates-for-covid-19-vaccines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-15_covid-19-vaccines-authorised-42</loc><lastmod>2026-10-23T18:04:02+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-15_covid-19-vaccines-authorised-42" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-15_ema-and-ecdc-updated-recommendations-on-additional-booster-doses-of-mrna-covid-19-vaccines</loc><lastmod>2026-10-23T18:04:03+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-15_ema-and-ecdc-updated-recommendations-on-additional-booster-doses-of-mrna-covid-19-vaccines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-15_federal-administrative-court-decision-c-3007-2021-from-3-june-2022</loc><lastmod>2026-10-23T18:04:04+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-15_federal-administrative-court-decision-c-3007-2021-from-3-june-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_federal-supreme-court-decision-2c-740-2021-from-17-may-2022</loc><lastmod>2026-10-23T18:04:05+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_federal-supreme-court-decision-2c-740-2021-from-17-may-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_the-federal-office-of-public-health-foph-supports-a-project-to-return-data-from-the-meineimpfungen-ch-platform</loc><lastmod>2026-10-23T18:04:04+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_the-federal-office-of-public-health-foph-supports-a-project-to-return-data-from-the-meineimpfungen-ch-platform" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_federal-quality-commission-eidgenoessische-qualitaetskommission-eqk-aims-to-improve-pa-tient-participation-and-quality-in-healthcare</loc><lastmod>2026-10-23T18:04:06+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_federal-quality-commission-eidgenoessische-qualitaetskommission-eqk-aims-to-improve-pa-tient-participation-and-quality-in-healthcare" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_amendment-to-the-ordinance-on-accident-insurance-possibility-of-paying-the-premiums-in-half-yearly-or-quarterly-instalments</loc><lastmod>2026-10-23T18:04:05+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_amendment-to-the-ordinance-on-accident-insurance-possibility-of-paying-the-premiums-in-half-yearly-or-quarterly-instalments" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_biomedical-research-and-technology-federal-council-approves-master-plan-for-2022-2026</loc><lastmod>2026-10-23T18:04:07+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_biomedical-research-and-technology-federal-council-approves-master-plan-for-2022-2026" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_patients-access-to-medicinal-cannabis-is-simplified</loc><lastmod>2026-10-23T18:04:07+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_patients-access-to-medicinal-cannabis-is-simplified" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_coronavirus-second-interim-report-specifies-impact-of-pandemic-on-health-costs</loc><lastmod>2026-10-23T18:04:06+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_coronavirus-second-interim-report-specifies-impact-of-pandemic-on-health-costs" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_supply-of-medical-devices-is-guaranteed</loc><lastmod>2026-10-23T18:04:08+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_supply-of-medical-devices-is-guaranteed" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_covid-19-overview-of-the-development-of-case-numbers-and-the-utilisation-of-the-health-care-system</loc><lastmod>2026-10-23T18:04:08+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_covid-19-overview-of-the-development-of-case-numbers-and-the-utilisation-of-the-health-care-system" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_moderna-applies-for-an-authorisation-extension-for-a-coronavirus-vaccine-against-omicron</loc><lastmod>2026-10-23T18:04:10+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_moderna-applies-for-an-authorisation-extension-for-a-coronavirus-vaccine-against-omicron" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_covid-19-further-booster-vaccination-recommended-for-people-aged-over-80-as-of-now</loc><lastmod>2026-10-23T18:04:09+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_covid-19-further-booster-vaccination-recommended-for-people-aged-over-80-as-of-now" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_from-1-september-2022-swissmedic-will-no-longer-issue-authorisations-for-the-import-of-veter-inary-medicinal-products-by-medical-professionals</loc><lastmod>2026-10-23T18:04:09+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_from-1-september-2022-swissmedic-will-no-longer-issue-authorisations-for-the-import-of-veter-inary-medicinal-products-by-medical-professionals" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_swissmedic-position-paper-on-the-use-of-real-world-evidence</loc><lastmod>2026-10-23T18:04:11+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_swissmedic-position-paper-on-the-use-of-real-world-evidence" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_changes-to-the-guidance-document-product-information-for-human-medicinal-products-hmv4</loc><lastmod>2026-10-23T18:04:10+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_changes-to-the-guidance-document-product-information-for-human-medicinal-products-hmv4" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_the-swissmedic-institute-council-has-put-addendum-10-8-of-the-european-pharmacopoeia-into-force-on-1-july-2022</loc><lastmod>2026-10-23T18:04:12+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_the-swissmedic-institute-council-has-put-addendum-10-8-of-the-european-pharmacopoeia-into-force-on-1-july-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_revision-of-the-therapeutic-products-licensing-requirements-ordinance</loc><lastmod>2026-10-23T18:04:12+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_revision-of-the-therapeutic-products-licensing-requirements-ordinance" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland---update-26</loc><lastmod>2026-10-23T18:04:11+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland---update-26" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_covid-19-vaccines-authorised-43</loc><lastmod>2026-10-23T18:04:13+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_covid-19-vaccines-authorised-43" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_covid-19-vaccines-clinical-data</loc><lastmod>2026-10-23T18:04:13+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_covid-19-vaccines-clinical-data" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_global-regulators-work-towards-strengthening-collaboration-on-observational-research-beyond-covid-19-pandemic</loc><lastmod>2026-10-23T18:04:14+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_global-regulators-work-towards-strengthening-collaboration-on-observational-research-beyond-covid-19-pandemic" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_covid-19-vaccines-authorised-44</loc><lastmod>2026-10-23T18:04:14+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_covid-19-vaccines-authorised-44" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-07-07_safety-of-covid-19-vaccines-3</loc><lastmod>2026-10-23T18:04:15+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-07-07_safety-of-covid-19-vaccines-3" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_more-flexible-dispensing-rules-for-heroin-assisted-treatment</loc><lastmod>2026-10-23T18:04:17+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_more-flexible-dispensing-rules-for-heroin-assisted-treatment" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_federal-council-approves-agreement-on-inpatient-rehabilitation</loc><lastmod>2026-10-23T18:04:16+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_federal-council-approves-agreement-on-inpatient-rehabilitation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_covid-19-federal-council-allows-easy-access-to-travel-vaccination</loc><lastmod>2026-10-23T18:04:17+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_covid-19-federal-council-allows-easy-access-to-travel-vaccination" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_paradigm-shift-in-tobacco-and-nicotine-prevention-among-children-and-adolescents</loc><lastmod>2026-10-23T18:04:18+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_paradigm-shift-in-tobacco-and-nicotine-prevention-among-children-and-adolescents" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_swissmedic-annual-report-2021-the-second-year-of-coronavirus-as-a-particular-challenge</loc><lastmod>2026-10-23T18:04:18+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_swissmedic-annual-report-2021-the-second-year-of-coronavirus-as-a-particular-challenge" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_update-on-the-replacement-of-the-medical-professions-register-medreg-by-the-new-health-professions-platform-healthreg</loc><lastmod>2026-10-23T18:04:19+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_update-on-the-replacement-of-the-medical-professions-register-medreg-by-the-new-health-professions-platform-healthreg" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_international-cooperation-on-therapeutic-products</loc><lastmod>2026-10-23T18:04:19+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_international-cooperation-on-therapeutic-products" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_swissmedic-approves-paxlovid-for-covid-19-patients</loc><lastmod>2026-10-23T18:04:20+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_swissmedic-approves-paxlovid-for-covid-19-patients" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_availability-of-medicines-during-covid-19-pandemic</loc><lastmod>2026-10-23T18:04:21+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_availability-of-medicines-during-covid-19-pandemic" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_covid-19-vaccines-clinical-data-2</loc><lastmod>2026-10-23T18:04:20+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_covid-19-vaccines-clinical-data-2" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_covid-19-vaccines-clinical-data-3</loc><lastmod>2026-10-23T18:04:21+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_covid-19-vaccines-clinical-data-3" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_covid-19-vaccines-adaptation-of-comirnaty</loc><lastmod>2026-10-23T18:04:22+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_covid-19-vaccines-adaptation-of-comirnaty" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-17_covid-19-vaccines-clinical-data-4</loc><lastmod>2026-10-23T18:04:22+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-17_covid-19-vaccines-clinical-data-4" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-10_consultation-procedure-regarding-amendment-of-the-health-insurance-ordinance-kvv-and-the-health-insurance-benefits-ordinance-klv-to-improve-the-equal-treatment-of-patients-by-health-insurers-in-individual-case-reimbursement-as-well-as-pric</loc><lastmod>2026-10-23T18:04:23+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-10_consultation-procedure-regarding-amendment-of-the-health-insurance-ordinance-kvv-and-the-health-insurance-benefits-ordinance-klv-to-improve-the-equal-treatment-of-patients-by-health-insurers-in-individual-case-reimbursement-as-well-as-pric" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-10_covid-19-vaccine-procurement-investigation-launched</loc><lastmod>2026-10-23T18:04:24+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-10_covid-19-vaccine-procurement-investigation-launched" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-10_federal-council-wants-to-extend-individual-provisions-in-the-covid-19-act</loc><lastmod>2026-10-23T18:04:23+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-10_federal-council-wants-to-extend-individual-provisions-in-the-covid-19-act" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-10_tardoc-encouraging-progress-but-not-yet-sufficient-for-approval</loc><lastmod>2026-10-23T18:04:24+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-10_tardoc-encouraging-progress-but-not-yet-sufficient-for-approval" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-10_laboratory-analyses-tariffs-are-lowered</loc><lastmod>2026-10-23T18:04:25+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-10_laboratory-analyses-tariffs-are-lowered" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-10_swissmedic-journal-3</loc><lastmod>2026-10-23T18:04:25+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-10_swissmedic-journal-3" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-10_covid-19-vaccines-authorised---jcovden-previously-covid-19-vaccine-janssen</loc><lastmod>2026-10-23T18:04:26+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-10_covid-19-vaccines-authorised---jcovden-previously-covid-19-vaccine-janssen" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-10_covid-19-vaccines-clinical-data-5</loc><lastmod>2026-10-23T18:04:26+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-10_covid-19-vaccines-clinical-data-5" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-10_treatments-and-vaccines-for-covid-19---ema-regular-press-briefing</loc><lastmod>2026-10-23T18:04:27+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-10_treatments-and-vaccines-for-covid-19---ema-regular-press-briefing" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-06-10_federal-administrative-court-decision-c-3057-2021-of-17-may-2022</loc><lastmod>2026-10-23T18:04:27+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-06-10_federal-administrative-court-decision-c-3057-2021-of-17-may-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-27_federal-council-wants-to-implement-the-training-offensive-in-the-healthcare-sector-as-quickly-as-possible</loc><lastmod>2026-10-23T18:04:29+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-27_federal-council-wants-to-implement-the-training-offensive-in-the-healthcare-sector-as-quickly-as-possible" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-27_hospital-financing-and-free-choice-of-hospital-progress-made-but-potential-for-improvement-not-yet-exhausted</loc><lastmod>2026-10-23T18:04:28+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-27_hospital-financing-and-free-choice-of-hospital-progress-made-but-potential-for-improvement-not-yet-exhausted" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-27_the-federal-office-of-public-health-foph-notes-that-users-of-the-electronic-vaccination-card-on-the-platform-are-unlikely-to-get-their-data-back-according-to-the-latest-recommendations-of-the-federal-data-protection-and-information</loc><lastmod>2026-10-23T18:04:30+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-27_the-federal-office-of-public-health-foph-notes-that-users-of-the-electronic-vaccination-card-on-the-platform-are-unlikely-to-get-their-data-back-according-to-the-latest-recommendations-of-the-federal-data-protection-and-information" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-27_outpatient-before-inpatient-shift-trend-confirmed</loc><lastmod>2026-10-23T18:04:30+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-27_outpatient-before-inpatient-shift-trend-confirmed" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-27_new-regulations-applicable-to-in-vitro-diagnostic-medical-devices-as-of-26-may-2022</loc><lastmod>2026-10-23T18:04:29+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-27_new-regulations-applicable-to-in-vitro-diagnostic-medical-devices-as-of-26-may-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-27_spikevax-covid-19-vaccine-for-children-up-to-5-years-application-for-indication-extension-sub-mitted</loc><lastmod>2026-10-23T18:04:31+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-27_spikevax-covid-19-vaccine-for-children-up-to-5-years-application-for-indication-extension-sub-mitted" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-27_treatments-and-vaccines-for-covid-19---ema-regular-press-briefing-on-covid-19</loc><lastmod>2026-10-23T18:04:31+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-27_treatments-and-vaccines-for-covid-19---ema-regular-press-briefing-on-covid-19" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-27_covid-19-vaccines-authorised---jcovden-previously-covid-19-vaccine-janssen-2</loc><lastmod>2026-10-23T18:04:32+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-27_covid-19-vaccines-authorised---jcovden-previously-covid-19-vaccine-janssen-2" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_covid-19-further-booster-vaccination-or-preventive-antibody-treatment-to-protect-people-with-severely-weakened-immune-system</loc><lastmod>2026-10-23T18:04:32+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_covid-19-further-booster-vaccination-or-preventive-antibody-treatment-to-protect-people-with-severely-weakened-immune-system" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_coronavirus-federal-council-adopts-policy-paper-on-goals-tasks-and-responsibilities-in-the-transition-phase</loc><lastmod>2026-10-23T18:04:34+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_coronavirus-federal-council-adopts-policy-paper-on-goals-tasks-and-responsibilities-in-the-transition-phase" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_stay-self-determined-consultation-on-model</loc><lastmod>2026-10-23T18:04:33+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_stay-self-determined-consultation-on-model" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_procurement-of-protective-masks-federal-council-appreciates-the-commitment-of-the-army-pharmacy</loc><lastmod>2026-10-23T18:04:33+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_procurement-of-protective-masks-federal-council-appreciates-the-commitment-of-the-army-pharmacy" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_the-confederation-signs-a-contract-for-the-procurement-of-paxlovid-for-the-treatment-of-covid-19</loc><lastmod>2026-10-23T18:04:35+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_the-confederation-signs-a-contract-for-the-procurement-of-paxlovid-for-the-treatment-of-covid-19" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_covid-19-vaccines-authorised---nuvaxovid</loc><lastmod>2026-10-23T18:04:35+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_covid-19-vaccines-authorised---nuvaxovid" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_covid-19-vaccines-authorised---comirnaty</loc><lastmod>2026-10-23T18:04:34+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_covid-19-vaccines-authorised---comirnaty" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_covid-19-vaccines-authorised---vaxzevria-previously-covid-19-vaccine-astrazeneca</loc><lastmod>2026-10-23T18:04:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_covid-19-vaccines-authorised---vaxzevria-previously-covid-19-vaccine-astrazeneca" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_covid-19-vaccines-under-evaluation-2</loc><lastmod>2026-10-23T18:04:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_covid-19-vaccines-under-evaluation-2" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_international-regulators-and-who-support-healthcare-professionals-to-enhance-public-confi-dence-in-covid-19-vaccines</loc><lastmod>2026-10-23T18:04:37+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_international-regulators-and-who-support-healthcare-professionals-to-enhance-public-confi-dence-in-covid-19-vaccines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-20_german-federal-institutional-court-decision-1-bvr-2649-21-from-27-april-2022</loc><lastmod>2026-10-23T18:04:37+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-20_german-federal-institutional-court-decision-1-bvr-2649-21-from-27-april-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-13_regulatory-training-for-french-speaking-authorities-in-may-2022</loc><lastmod>2026-10-23T18:04:38+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-13_regulatory-training-for-french-speaking-authorities-in-may-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-13_moderna-covid-19-vaccine-authorised-in-switzerland-for-children-aged-6-to-11-years</loc><lastmod>2026-10-23T18:04:39+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-13_moderna-covid-19-vaccine-authorised-in-switzerland-for-children-aged-6-to-11-years" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-13_covid-19-vaccines-authorised---spikevax-previously-covid-19-vaccine-moderna</loc><lastmod>2026-10-23T18:04:38+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-13_covid-19-vaccines-authorised---spikevax-previously-covid-19-vaccine-moderna" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-13_update-safety-of-covid-19-vaccines</loc><lastmod>2026-10-23T18:04:39+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-13_update-safety-of-covid-19-vaccines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-13_federal-supreme-court-decision-9c-400-2021-of-20-april-2022</loc><lastmod>2026-10-23T18:04:40+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-13_federal-supreme-court-decision-9c-400-2021-of-20-april-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-06_covid-19-treatments-authorised---evusheld</loc><lastmod>2026-10-23T18:04:40+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-06_covid-19-treatments-authorised---evusheld" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-06_treatment-and-vaccines-for-covid-19---ema-regular-press-briefing-on-covid-19</loc><lastmod>2026-10-23T18:04:41+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-06_treatment-and-vaccines-for-covid-19---ema-regular-press-briefing-on-covid-19" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-06_organ-donation-register-is-still-blocked</loc><lastmod>2026-10-23T18:04:41+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-06_organ-donation-register-is-still-blocked" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-06_covid-19-federal-government-expands-wastewater-monitoring-to-over-100-wastewater-treatment-plants</loc><lastmod>2026-10-23T18:04:42+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-06_covid-19-federal-government-expands-wastewater-monitoring-to-over-100-wastewater-treatment-plants" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-06_federal-council-increases-safety-of-in-vitro-diagnostics</loc><lastmod>2026-10-23T18:04:42+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-06_federal-council-increases-safety-of-in-vitro-diagnostics" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-06_federal-council-wants-to-enable-research-to-make-better-use-of-health-data</loc><lastmod>2026-10-23T18:04:43+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-06_federal-council-wants-to-enable-research-to-make-better-use-of-health-data" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-06_diagnostic-neuropsychology-federal-council-approves-tariff-point-value</loc><lastmod>2026-10-23T18:04:43+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-06_diagnostic-neuropsychology-federal-council-approves-tariff-point-value" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-06_technical-requirements-for-the-submission-of-clinical-trial-applications-for-medicinal-products</loc><lastmod>2026-10-23T18:04:44+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-06_technical-requirements-for-the-submission-of-clinical-trial-applications-for-medicinal-products" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-06_swissmedic-journal-4</loc><lastmod>2026-10-23T18:04:44+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-06_swissmedic-journal-4" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-05-06_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland-2</loc><lastmod>2026-10-23T18:04:45+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-05-06_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland-2" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_evaluation-of-covid-19-crisis-management-recommendations-to-the-federal-office-of-public-health</loc><lastmod>2026-10-23T18:04:45+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_evaluation-of-covid-19-crisis-management-recommendations-to-the-federal-office-of-public-health" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_federal-council-requests-extension-of-certain-provisions-in-the-covid-19-act</loc><lastmod>2026-10-23T18:04:46+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_federal-council-requests-extension-of-certain-provisions-in-the-covid-19-act" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_the-federal-council-wants-to-further-develop-the-electronic-patient-dossier</loc><lastmod>2026-10-23T18:04:46+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_the-federal-council-wants-to-further-develop-the-electronic-patient-dossier" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_covid-19-adaptation-of-the-covid-certificates-to-the-eu</loc><lastmod>2026-10-23T18:04:47+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_covid-19-adaptation-of-the-covid-certificates-to-the-eu" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_nccs-impacts-program-upcoming-call-for-project-proposals</loc><lastmod>2026-10-23T18:04:47+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_nccs-impacts-program-upcoming-call-for-project-proposals" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_the-revision-of-chapters-17-1-and-17-2-of-pharmacopoea-helvetica-12</loc><lastmod>2026-10-23T18:04:48+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_the-revision-of-chapters-17-1-and-17-2-of-pharmacopoea-helvetica-12" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_changes-to-guidance-document-authorization-procedures-for-covid-19-medicinal-products-during-a-pandemic-hmv-4---clarifications-on-the-prioritization-and-fast-tracking-of-pandemic-medicinal-products-and-on-the-patient-information-requiremen</loc><lastmod>2026-10-23T18:04:48+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_changes-to-guidance-document-authorization-procedures-for-covid-19-medicinal-products-during-a-pandemic-hmv-4---clarifications-on-the-prioritization-and-fast-tracking-of-pandemic-medicinal-products-and-on-the-patient-information-requiremen" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_out-of-stock---covid-19---authorizations-for-the-temporary-import-and-distribution-of-human-medicines</loc><lastmod>2026-10-23T18:04:49+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_out-of-stock---covid-19---authorizations-for-the-temporary-import-and-distribution-of-human-medicines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_covid-19-treatments-authorized---evusheld</loc><lastmod>2026-10-23T18:04:49+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_covid-19-treatments-authorized---evusheld" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_covid-19-vaccines-authorized---jcovden-previously-covid-19-vaccine-janssen</loc><lastmod>2026-10-23T18:04:50+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_covid-19-vaccines-authorized---jcovden-previously-covid-19-vaccine-janssen" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_treatments-and-vaccines-for-covid-19---ema-regular-press-briefing-on-covid-19-2</loc><lastmod>2026-10-23T18:04:50+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_treatments-and-vaccines-for-covid-19---ema-regular-press-briefing-on-covid-19-2" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_covid-19-guidance-research-and-development</loc><lastmod>2026-10-23T18:04:51+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_covid-19-guidance-research-and-development" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_plastic-surgery-clinics-circumvent-advertising-ban</loc><lastmod>2026-10-23T18:04:51+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_plastic-surgery-clinics-circumvent-advertising-ban" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-29_federal-supreme-court-decision-9c-460-2021-from-1-april-2022</loc><lastmod>2026-10-23T18:04:52+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-29_federal-supreme-court-decision-9c-460-2021-from-1-april-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-22_the-confederation-approves-first-application-for-a-cannabis-pilot-trial-in-basel-stadt</loc><lastmod>2026-10-23T18:04:53+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-22_the-confederation-approves-first-application-for-a-cannabis-pilot-trial-in-basel-stadt" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-22_dhpc-anagrelide-containing-medicinal-products-increased-risk-of-thrombosis-including-cerebral-infarction-after-abrupt-discontinuation-of-treatment</loc><lastmod>2026-10-23T18:04:53+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-22_dhpc-anagrelide-containing-medicinal-products-increased-risk-of-thrombosis-including-cerebral-infarction-after-abrupt-discontinuation-of-treatment" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-22_comirnaty-concentrate-for-the-preparation-of-a-dispersion-for-injection-new-shelf-life-with-ultra-low-refrigeration</loc><lastmod>2026-10-23T18:04:54+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-22_comirnaty-concentrate-for-the-preparation-of-a-dispersion-for-injection-new-shelf-life-with-ultra-low-refrigeration" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-22_batch-recall---accupro-film-coated-tablets</loc><lastmod>2026-10-23T18:04:54+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-22_batch-recall---accupro-film-coated-tablets" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-22_facilitating-global-access-to-diabetes-treatments-for-non-eu-patients</loc><lastmod>2026-10-23T18:04:55+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-22_facilitating-global-access-to-diabetes-treatments-for-non-eu-patients" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-22_covid-19-vaccines-authorized-4</loc><lastmod>2026-10-23T18:04:56+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-22_covid-19-vaccines-authorized-4" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-22_swissmedic-grants-temporary-authorization-for-the-nuvaxovid-covid-19-vaccine-from-novavax</loc><lastmod>2026-10-23T18:04:55+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-22_swissmedic-grants-temporary-authorization-for-the-nuvaxovid-covid-19-vaccine-from-novavax" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-22_hepatitis-who-reports-mysterious-cases-in-children</loc><lastmod>2026-10-23T18:04:56+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-22_hepatitis-who-reports-mysterious-cases-in-children" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-22_famh-laboratory-code-of-conduct</loc><lastmod>2026-10-23T18:04:57+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-22_famh-laboratory-code-of-conduct" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-22_federal-supreme-court-decision-9c-188-2021-from-17-march-2022</loc><lastmod>2026-10-23T18:30:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-22_federal-supreme-court-decision-9c-188-2021-from-17-march-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-15_federal-council-approves-extension-of-the-radium-action-plan-until-the-end-of-2023</loc><lastmod>2026-10-23T18:04:58+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-15_federal-council-approves-extension-of-the-radium-action-plan-until-the-end-of-2023" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-15_covid-19-vaccine-protein-based-nuvaxovid-available</loc><lastmod>2026-10-23T18:04:58+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-15_covid-19-vaccine-protein-based-nuvaxovid-available" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-15_twelve-rather-than-nine-month-shelf-life-for-pfizer-biontech-vaccine</loc><lastmod>2026-10-23T18:04:59+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-15_twelve-rather-than-nine-month-shelf-life-for-pfizer-biontech-vaccine" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_public-consultation-on-guidelines-of-the-international-council-for-harmonisation-ich-guidelines</loc><lastmod>2026-10-23T18:04:59+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_public-consultation-on-guidelines-of-the-international-council-for-harmonisation-ich-guidelines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_roundtable-on-medical-technology-rtmt</loc><lastmod>2026-10-23T18:05:00+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_roundtable-on-medical-technology-rtmt" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_ecdc-and-ema-issue-advice-on-fourth-doses-of-mrna-covid-19-vaccines</loc><lastmod>2026-10-23T18:05:00+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_ecdc-and-ema-issue-advice-on-fourth-doses-of-mrna-covid-19-vaccines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_federal-administrative-court-decision-b-413-2020-from-28-march-2022</loc><lastmod>2026-10-23T18:05:01+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_federal-administrative-court-decision-b-413-2020-from-28-march-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_coronavirus-return-to-normal-and-planning-for-the-transition-phase-until-spring-2023</loc><lastmod>2026-10-23T18:05:02+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_coronavirus-return-to-normal-and-planning-for-the-transition-phase-until-spring-2023" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_addendum-10-7-of-the-european-pharmacopoeia-in-force</loc><lastmod>2026-10-23T18:05:01+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_addendum-10-7-of-the-european-pharmacopoeia-in-force" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_aid-for-ukraine-export-of-medicinal-products-to-the-conflict-area---update</loc><lastmod>2026-10-23T18:05:02+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_aid-for-ukraine-export-of-medicinal-products-to-the-conflict-area---update" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_risk-management-signalmanagement-psurs-rmps-rmp-summaries</loc><lastmod>2026-10-23T18:05:03+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_risk-management-signalmanagement-psurs-rmps-rmp-summaries" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_ema-establishes-cancer-medicines-forum-with-academia-to-optimise-cancer-treatments-in-clinical-practice</loc><lastmod>2026-10-23T18:05:03+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_ema-establishes-cancer-medicines-forum-with-academia-to-optimise-cancer-treatments-in-clinical-practice" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_federal-administrative-court-decision-b-2923-2020-from-17-march-2022</loc><lastmod>2026-10-23T18:05:04+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_federal-administrative-court-decision-b-2923-2020-from-17-march-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-08_federal-administrative-court-decision-b-2844-2020-from-18-march-2022</loc><lastmod>2026-10-23T18:05:04+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-08_federal-administrative-court-decision-b-2844-2020-from-18-march-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-01_federal-administrative-court-decision-c-2635-2021-from-7-march-2022</loc><lastmod>2026-10-23T18:05:06+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-01_federal-administrative-court-decision-c-2635-2021-from-7-march-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-01_federal-administrative-court-decision-c-1361-2019-from-9-march-2022</loc><lastmod>2026-10-23T18:05:07+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-01_federal-administrative-court-decision-c-1361-2019-from-9-march-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-01_federal-administrative-court-decision-c-6596-2018-from-15-march-2022</loc><lastmod>2026-10-23T18:05:06+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-01_federal-administrative-court-decision-c-6596-2018-from-15-march-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-01_information-event</loc><lastmod>2026-10-23T18:05:07+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-01_information-event" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-04-01_ordinance-on-health-care-services-klv-annex-3-list-of-analyses-al</loc><lastmod>2026-10-23T18:05:08+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-04-01_ordinance-on-health-care-services-klv-annex-3-list-of-analyses-al" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-25_cost-containment-in-the-healthcare-system-federal-council-sends-further-measures-for-consultation</loc><lastmod>2026-10-23T18:05:09+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-25_cost-containment-in-the-healthcare-system-federal-council-sends-further-measures-for-consultation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-25_the-federal-council-improves-the-labelling-of-chemicals</loc><lastmod>2026-10-23T18:05:10+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-25_the-federal-council-improves-the-labelling-of-chemicals" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-25_coronavirus-the-confederation-secures-vaccine-supply-for-2023</loc><lastmod>2026-10-23T18:05:09+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-25_coronavirus-the-confederation-secures-vaccine-supply-for-2023" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-25_war-in-ukraine-export-of-medicinal-products-to-the-conflict-area</loc><lastmod>2026-10-23T18:05:10+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-25_war-in-ukraine-export-of-medicinal-products-to-the-conflict-area" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-25_federal-administrative-court-decision-a-4911-2021-from-1-march-2022</loc><lastmod>2026-10-23T18:05:11+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-25_federal-administrative-court-decision-a-4911-2021-from-1-march-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-18_corona-new-period-of-validity-of-the-certificate-of-recovered-persons-and-facilitated-entry-from-third-countries</loc><lastmod>2026-10-23T18:05:11+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-18_corona-new-period-of-validity-of-the-certificate-of-recovered-persons-and-facilitated-entry-from-third-countries" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-18_a-gene-could-prevent-parkinsons-disease</loc><lastmod>2026-10-23T18:05:12+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-18_a-gene-could-prevent-parkinsons-disease" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-18_a-gene-could-prevent-parkinsons-disease-2</loc><lastmod>2026-10-23T18:05:12+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-18_a-gene-could-prevent-parkinsons-disease-2" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-04_miracle-mineral-supplement-mms-covid-19-lozenges-and-other-wonder-drugs-swissmedic-issues-another-warning-against-contact-with-the-caustic-substance-chlorine-dioxide</loc><lastmod>2026-10-23T18:05:13+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-04_miracle-mineral-supplement-mms-covid-19-lozenges-and-other-wonder-drugs-swissmedic-issues-another-warning-against-contact-with-the-caustic-substance-chlorine-dioxide" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-04_unique-identification-number-chrn---swiss-single-registration-number</loc><lastmod>2026-10-23T18:05:14+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-04_unique-identification-number-chrn---swiss-single-registration-number" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-04_regulation-on-emas-extended-mandate-becomes-applicable</loc><lastmod>2026-10-23T18:05:14+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-04_regulation-on-emas-extended-mandate-becomes-applicable" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-04_prime-enables-earlier-availability-of-life-changing-medicines</loc><lastmod>2026-10-23T18:05:13+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-04_prime-enables-earlier-availability-of-life-changing-medicines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-03-04_federal-supreme-court-decision-9c-8-2021-from-8-february-2022</loc><lastmod>2026-10-23T18:05:15+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-03-04_federal-supreme-court-decision-9c-8-2021-from-8-february-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-25_donation-of-covid-19-vaccines-and-procurement-of-drugs-for-passive-immunization-against-covid-19</loc><lastmod>2026-10-23T18:05:16+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-25_donation-of-covid-19-vaccines-and-procurement-of-drugs-for-passive-immunization-against-covid-19" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-25_organ-donation-federal-council-and-parliament-in-favor-of-objection-solution-with-inclusion-of-relatives</loc><lastmod>2026-10-23T18:05:17+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-25_organ-donation-federal-council-and-parliament-in-favor-of-objection-solution-with-inclusion-of-relatives" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-25_data-protection-for-special-forms-of-insurance-has-improved</loc><lastmod>2026-10-23T18:05:16+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-25_data-protection-for-special-forms-of-insurance-has-improved" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-25_illegal-imports-2021-swissmedic-seizes-significantly-more-packages-than-in-2020</loc><lastmod>2026-10-23T18:05:17+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-25_illegal-imports-2021-swissmedic-seizes-significantly-more-packages-than-in-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-25_authorisations-of-human-medicinal-products-with-a-new-active-substance-and-additional-indications-2021</loc><lastmod>2026-10-23T18:05:18+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-25_authorisations-of-human-medicinal-products-with-a-new-active-substance-and-additional-indications-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-25_european-medicines-regulatory-network-adopts-eu-common-standard-for-electronic-product-information</loc><lastmod>2026-10-23T18:05:18+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-25_european-medicines-regulatory-network-adopts-eu-common-standard-for-electronic-product-information" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-25_ema-recommends-approval-of-spikevax-for-children-aged-6-to-11</loc><lastmod>2026-10-23T18:05:19+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-25_ema-recommends-approval-of-spikevax-for-children-aged-6-to-11" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-25_ema-recommends-authorisation-of-booster-doses-of-comirnaty-from-12-years-of-age</loc><lastmod>2026-10-23T18:05:19+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-25_ema-recommends-authorisation-of-booster-doses-of-comirnaty-from-12-years-of-age" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-25_hydroxyethyl-starch-solutions-for-infusion-recommended-for-suspension-from-the-market</loc><lastmod>2026-10-23T18:05:20+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-25_hydroxyethyl-starch-solutions-for-infusion-recommended-for-suspension-from-the-market" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-25_new-medicine-for-rare-type-of-eye-cancer</loc><lastmod>2026-10-23T18:05:20+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-25_new-medicine-for-rare-type-of-eye-cancer" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-18_federal-supreme-court-decision-bge-2c-15-2022-from-26-january-2022</loc><lastmod>2026-10-23T18:05:21+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-18_federal-supreme-court-decision-bge-2c-15-2022-from-26-january-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-18_federal-administrative-court-decision-c-3194-2019-from-20-january-2022</loc><lastmod>2026-10-23T18:05:21+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-18_federal-administrative-court-decision-c-3194-2019-from-20-january-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-18_federal-administrative-court-decision-c-5955-2019-from-28-january-2022</loc><lastmod>2026-10-23T18:05:22+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-18_federal-administrative-court-decision-c-5955-2019-from-28-january-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-18_validity-of-gmp-certificates-during-the-covid-19-pandemic</loc><lastmod>2026-10-23T18:05:22+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-18_validity-of-gmp-certificates-during-the-covid-19-pandemic" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-18_federal-councilor-alain-berset-signs-social-security-agreement-with-albania-in-tirana</loc><lastmod>2026-10-23T18:05:23+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-18_federal-councilor-alain-berset-signs-social-security-agreement-with-albania-in-tirana" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-18_supply-problems-for-human-medicines-foph-report-shows-optimization-approaches</loc><lastmod>2026-10-23T18:05:23+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-18_supply-problems-for-human-medicines-foph-report-shows-optimization-approaches" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-18_coronavirus-federal-council-lifts-measures---mask-requirements-on-public-transport-and-in-healthcare-institutions-and-isolation-in-the-event-of-illness-to-remain-until-end-of-march</loc><lastmod>2026-10-23T18:05:24+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-18_coronavirus-federal-council-lifts-measures---mask-requirements-on-public-transport-and-in-healthcare-institutions-and-isolation-in-the-event-of-illness-to-remain-until-end-of-march" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-15_federal-administrative-court-decision-c-642-2018-from-20-january-2022</loc><lastmod>2026-10-23T18:05:24+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-15_federal-administrative-court-decision-c-642-2018-from-20-january-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-15_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-3</loc><lastmod>2026-10-23T18:05:25+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-15_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-3" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-15_initiation-of-darwin-eu-coordination-centre-advances-integration-of-real-world-evidence-into-assessment-of-medicines-in-the-eu</loc><lastmod>2026-10-23T18:05:25+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-15_initiation-of-darwin-eu-coordination-centre-advances-integration-of-real-world-evidence-into-assessment-of-medicines-in-the-eu" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-15_public-consultation-on-reflection-paper-on-prophylactic-use-of-antimicrobials-in-animals</loc><lastmod>2026-10-23T18:05:26+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-15_public-consultation-on-reflection-paper-on-prophylactic-use-of-antimicrobials-in-animals" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-15_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland---update-22</loc><lastmod>2026-10-23T18:05:26+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-15_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland---update-22" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-15_batch-recall---hextril-spray</loc><lastmod>2026-10-23T18:05:27+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-15_batch-recall---hextril-spray" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-15_swiss-federal-government-reserves-2000-packs-of-a-drug-to-treat-covid-19</loc><lastmod>2026-10-23T18:05:27+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-15_swiss-federal-government-reserves-2000-packs-of-a-drug-to-treat-covid-19" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-15_federal-councilor-alain-berset-at-the-meeting-of-eu-health-ministers-in-grenoble</loc><lastmod>2026-10-23T18:05:28+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-15_federal-councilor-alain-berset-at-the-meeting-of-eu-health-ministers-in-grenoble" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-10_regulation-eu-2022-123-on-a-reinforced-role-for-the-european-medicines-agency-in-crisis-preparedness-and-management-for-medicinal-products-and-medical-devices</loc><lastmod>2026-10-23T18:05:28+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-10_regulation-eu-2022-123-on-a-reinforced-role-for-the-european-medicines-agency-in-crisis-preparedness-and-management-for-medicinal-products-and-medical-devices" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-10_coronavirus-ema-published-the-full-risk-management-plan-for-pfizer-s-covid-19-treatment-paxlovid</loc><lastmod>2026-10-23T18:05:29+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-10_coronavirus-ema-published-the-full-risk-management-plan-for-pfizer-s-covid-19-treatment-paxlovid" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-10_out-of-stock---covid-19---authorisation-for-the-temporary-import-and-distribution-of-human-medicines-update-2-february-2022</loc><lastmod>2026-10-23T18:05:29+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-10_out-of-stock---covid-19---authorisation-for-the-temporary-import-and-distribution-of-human-medicines-update-2-february-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-10_use-of-titanium-dioxide-in-medicinal-products</loc><lastmod>2026-10-23T18:05:30+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-10_use-of-titanium-dioxide-in-medicinal-products" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-10_coronavirus-federal-council-lifts-requirements-to-quarantine-and-to-work-from-home-and-launches-consultation-on-a-widespread-easing-of-measures</loc><lastmod>2026-10-23T18:05:30+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-10_coronavirus-federal-council-lifts-requirements-to-quarantine-and-to-work-from-home-and-launches-consultation-on-a-widespread-easing-of-measures" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-01_germany-recognises-sqs-certificates</loc><lastmod>2026-10-23T18:05:31+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-01_germany-recognises-sqs-certificates" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-01_ema-regulatory-harmonisation-of-clinical-trials-in-the-eu-clinical-trials-regulation-to-enter-into-application-and-new-clinical-trials-information-system-to-be-launched</loc><lastmod>2026-10-23T18:05:33+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-01_ema-regulatory-harmonisation-of-clinical-trials-in-the-eu-clinical-trials-regulation-to-enter-into-application-and-new-clinical-trials-information-system-to-be-launched" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-01_ema-new-eu-rules-for-safe-and-high-quality-medicines-for-animals-become-effective</loc><lastmod>2026-10-23T18:05:32+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-01_ema-new-eu-rules-for-safe-and-high-quality-medicines-for-animals-become-effective" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-01_new-versions-of-the-application-forms-for-operating-licences-are-applicable-as-of-28-january-2022</loc><lastmod>2026-10-23T18:05:32+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-01_new-versions-of-the-application-forms-for-operating-licences-are-applicable-as-of-28-january-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-02-01_early-revision-of-ordinance-on-veterinary-medicinal-products-legislation</loc><lastmod>2026-10-23T18:05:33+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-02-01_early-revision-of-ordinance-on-veterinary-medicinal-products-legislation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-28_federal-supreme-court-decision-9c-740-2020-from-14-december-2021</loc><lastmod>2026-10-23T18:05:35+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-28_federal-supreme-court-decision-9c-740-2020-from-14-december-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-28_federal-administrative-court-decision-c-2652-2019-from-22-december-2021</loc><lastmod>2026-10-23T18:05:34+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-28_federal-administrative-court-decision-c-2652-2019-from-22-december-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-28_federal-administrative-court-decision-c-641-2018-from-1-december-2021</loc><lastmod>2026-10-23T18:05:34+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-28_federal-administrative-court-decision-c-641-2018-from-1-december-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-28_reprocessing</loc><lastmod>2026-10-23T18:05:35+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-28_reprocessing" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-28_covid-19-booster-with-mrna-vaccines-extended-to-12-to-15-year-olds-and-second-dose-of-janssen-vaccine-recommended</loc><lastmod>2026-10-23T18:05:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-28_covid-19-booster-with-mrna-vaccines-extended-to-12-to-15-year-olds-and-second-dose-of-janssen-vaccine-recommended" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-24_accelerating-clinical-trials-in-the-eu-act-eu-for-better-clinical-trials-that-address-patients-needs</loc><lastmod>2026-10-23T18:05:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-24_accelerating-clinical-trials-in-the-eu-act-eu-for-better-clinical-trials-that-address-patients-needs" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-24_preliminary-data-indicate-covid-19-vaccines-remain-effective-against-severe-disease-and-hospitalisation-caused-by-the-omicron-variant</loc><lastmod>2026-10-23T18:05:37+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-24_preliminary-data-indicate-covid-19-vaccines-remain-effective-against-severe-disease-and-hospitalisation-caused-by-the-omicron-variant" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-24_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland---update-21</loc><lastmod>2026-10-23T18:05:37+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-24_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland---update-21" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-24_care-initiative-federal-council-recommends-implementation-in-two-stages</loc><lastmod>2026-10-23T18:05:38+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-24_care-initiative-federal-council-recommends-implementation-in-two-stages" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-24_coronavirus-quarantine-and-requirement-to-work-from-home-apply-until-end-of-february-other-measures-provisionally-until-end-of-march</loc><lastmod>2026-10-23T18:05:38+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-24_coronavirus-quarantine-and-requirement-to-work-from-home-apply-until-end-of-february-other-measures-provisionally-until-end-of-march" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-24_federal-supreme-court-decision-1c-692-2020-from-9-december-2021</loc><lastmod>2026-10-23T18:05:39+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-24_federal-supreme-court-decision-1c-692-2020-from-9-december-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-24_federal-supreme-court-decision-9c-736-2020-from-10-december-2021</loc><lastmod>2026-10-23T18:05:39+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-24_federal-supreme-court-decision-9c-736-2020-from-10-december-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2022-01-24_federal-administrative-court-decision-c-6306-2019-from-15-december-2021</loc><lastmod>2026-10-23T18:05:40+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2022-01-24_federal-administrative-court-decision-c-6306-2019-from-15-december-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-31_federal-supreme-court-decision-2c-310-2021-from-29-november-2021</loc><lastmod>2026-10-23T18:05:41+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-31_federal-supreme-court-decision-2c-310-2021-from-29-november-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-31_federal-administrative-court-decision-c-6601-2018-from-17-november-2021</loc><lastmod>2026-10-23T18:05:41+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-31_federal-administrative-court-decision-c-6601-2018-from-17-november-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-31_swissmedic-approves-ronaprever-for-covid-19-patients</loc><lastmod>2026-10-23T18:05:42+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-31_swissmedic-approves-ronaprever-for-covid-19-patients" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-31_update-of-the-information-sheet-on-the-obligations-of-economic-operators-medical-devices</loc><lastmod>2026-10-23T18:05:42+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-31_update-of-the-information-sheet-on-the-obligations-of-economic-operators-medical-devices" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-31_changes-to-the-guidance-document-temporary-authorisation-of-human-medicinal-products-hmv4</loc><lastmod>2026-10-23T18:05:43+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-31_changes-to-the-guidance-document-temporary-authorisation-of-human-medicinal-products-hmv4" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-24_ema-nuvaxovid-is-now-authorised-across-the-eu</loc><lastmod>2026-10-23T18:05:44+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-24_ema-nuvaxovid-is-now-authorised-across-the-eu" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-24_notification-of-medical-devices</loc><lastmod>2026-10-23T18:05:44+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-24_notification-of-medical-devices" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-24_clinical-trials-on-medicinal-products</loc><lastmod>2026-10-23T18:05:43+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-24_clinical-trials-on-medicinal-products" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-24_reports-on-the-activities-of-the-ethics-committees-and-human-research</loc><lastmod>2026-10-23T18:05:45+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-24_reports-on-the-activities-of-the-ethics-committees-and-human-research" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-24_covid-19-a-booster-vaccination-four-months-after-initial-immunisation-is-recommended-for-all-and-is-useful</loc><lastmod>2026-10-23T18:05:45+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-24_covid-19-a-booster-vaccination-four-months-after-initial-immunisation-is-recommended-for-all-and-is-useful" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-17_coronavirus-federal-council-introduces-tighter-measures</loc><lastmod>2026-10-23T18:05:46+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-17_coronavirus-federal-council-introduces-tighter-measures" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-17_covid-19-vaccination-recommended-and-possible-for-children-from-the-beginning-of-january</loc><lastmod>2026-10-23T18:05:47+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-17_covid-19-vaccination-recommended-and-possible-for-children-from-the-beginning-of-january" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-17_federal-government-signs-four-contracts-for-the-development-of-covid-19-medicines</loc><lastmod>2026-10-23T18:05:46+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-17_federal-government-signs-four-contracts-for-the-development-of-covid-19-medicines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-17_out-of-stock---covid-19---authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update-3</loc><lastmod>2026-10-23T18:05:47+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-17_out-of-stock---covid-19---authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update-3" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-10_winter-session-of-the-council-of-states-vote-on-various-motions-in-connection-with-cost-containment-as-well-as-the-cost-containment-measures-package-1</loc><lastmod>2026-10-23T18:05:48+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-10_winter-session-of-the-council-of-states-vote-on-various-motions-in-connection-with-cost-containment-as-well-as-the-cost-containment-measures-package-1" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-10_outpatient-before-inpatient-monitoring-confirms-shift</loc><lastmod>2026-10-23T18:05:49+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-10_outpatient-before-inpatient-monitoring-confirms-shift" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-10_12-individual-substances-and-one-substance-group-added-to-the-narcotics-list</loc><lastmod>2026-10-23T18:05:48+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-10_12-individual-substances-and-one-substance-group-added-to-the-narcotics-list" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-10_swissmedic-approves-covid-19-vaccine-from-pfizer-biontech-for-children-aged-5-to-11-years</loc><lastmod>2026-10-23T18:05:49+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-10_swissmedic-approves-covid-19-vaccine-from-pfizer-biontech-for-children-aged-5-to-11-years" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-03_federal-administrative-court-decision-c-5960-2019-from-12-november-2021</loc><lastmod>2026-10-23T18:05:50+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-03_federal-administrative-court-decision-c-5960-2019-from-12-november-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-03_federal-administrative-court-decision-c-1205-2018-from-8-november-2021</loc><lastmod>2026-10-23T18:05:50+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-03_federal-administrative-court-decision-c-1205-2018-from-8-november-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-03_coronavirus-covid-19-vaccinations-will-continue-to-be-free-of-charge-for-the-population-in-2022</loc><lastmod>2026-10-23T18:05:51+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-03_coronavirus-covid-19-vaccinations-will-continue-to-be-free-of-charge-for-the-population-in-2022" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-03_coronavirus-federal-council-tightens-measures-against-the-pandemic</loc><lastmod>2026-10-23T18:05:52+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-03_coronavirus-federal-council-tightens-measures-against-the-pandemic" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-03_supervisory-levy-2021-self-declaration</loc><lastmod>2026-10-23T18:05:51+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-03_supervisory-levy-2021-self-declaration" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-03_federal-council-approves-national-tariff-structures</loc><lastmod>2026-10-23T18:05:53+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-03_federal-council-approves-national-tariff-structures" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-03_healthcare-federal-council-enacts-measures-to-curb-cost-growth</loc><lastmod>2026-10-23T18:05:52+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-03_healthcare-federal-council-enacts-measures-to-curb-cost-growth" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-12-03_diagnostic-neuropsychology-federal-council-approves-tax-point-value</loc><lastmod>2026-10-23T18:05:53+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-12-03_diagnostic-neuropsychology-federal-council-approves-tax-point-value" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-26_federal-administrative-court-decision-c-415-2020-from-16-november-2021</loc><lastmod>2026-10-23T18:05:54+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-26_federal-administrative-court-decision-c-415-2020-from-16-november-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-26_federal-administrative-court-decision-c-6605-2018-from-4-november-2021</loc><lastmod>2026-10-23T18:05:54+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-26_federal-administrative-court-decision-c-6605-2018-from-4-november-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-26_swissmedic-authorises-booster-vaccination-with-modernas-covid-19-vaccine-for-adults-aged-18-years-and-older</loc><lastmod>2026-10-23T18:05:55+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-26_swissmedic-authorises-booster-vaccination-with-modernas-covid-19-vaccine-for-adults-aged-18-years-and-older" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-26_covid-19-vaccine-from-pfizer-biontech-swissmedic-approves-the-extension-of-the-booster-dose-to-all-persons-aged-16-years-and-older</loc><lastmod>2026-10-23T18:05:55+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-26_covid-19-vaccine-from-pfizer-biontech-swissmedic-approves-the-extension-of-the-booster-dose-to-all-persons-aged-16-years-and-older" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-26_federal-council-wants-to-revise-rules-on-mail-order-sales-of-non-prescription-medicines</loc><lastmod>2026-10-23T18:05:56+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-26_federal-council-wants-to-revise-rules-on-mail-order-sales-of-non-prescription-medicines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-26_coronavirus-booster-vaccination-for-all-improves-protection-and-slows-virus-spread</loc><lastmod>2026-10-23T18:05:56+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-26_coronavirus-booster-vaccination-for-all-improves-protection-and-slows-virus-spread" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-26_coronavirus-confederation-signs-contract-to-reserve-a-medicinal-product</loc><lastmod>2026-10-23T18:05:57+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-26_coronavirus-confederation-signs-contract-to-reserve-a-medicinal-product" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-19_federal-council-registration-and-publication-of-cancer-cases-will-be-simplified</loc><lastmod>2026-10-23T18:05:57+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-19_federal-council-registration-and-publication-of-cancer-cases-will-be-simplified" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-19_federal-council-wants-to-simplify-electronic-data-exchange-between-cantons-and-health-insurers</loc><lastmod>2026-10-23T18:05:58+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-19_federal-council-wants-to-simplify-electronic-data-exchange-between-cantons-and-health-insurers" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-12_federal-administrative-court-decision-c-6896-2019-from-29-october-2021</loc><lastmod>2026-10-23T18:05:59+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-12_federal-administrative-court-decision-c-6896-2019-from-29-october-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-12_federal-administrative-court-decision-c-6892-2019-from-28-october-2021</loc><lastmod>2026-10-23T18:05:58+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-12_federal-administrative-court-decision-c-6892-2019-from-28-october-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-12_federal-administrative-court-decision-c-3925-2019-from-30-march-2021</loc><lastmod>2026-10-23T18:05:59+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-12_federal-administrative-court-decision-c-3925-2019-from-30-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-12_federal-administrative-court-decision-c-5710-2019-from-24-september-2021-and-decision-c-5720-2019-from-24-september-2021</loc><lastmod>2026-10-23T18:06:00+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-12_federal-administrative-court-decision-c-5710-2019-from-24-september-2021-and-decision-c-5720-2019-from-24-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-12_federal-administrative-court-decision-c-5962-2019-from-25-october-2021</loc><lastmod>2026-10-23T18:06:00+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-12_federal-administrative-court-decision-c-5962-2019-from-25-october-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-12_coronavirus-annual-vaccinovigilance-reports</loc><lastmod>2026-10-23T18:06:01+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-12_coronavirus-annual-vaccinovigilance-reports" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-12_federal-council-rejects-cost-brake-initiative-and-adopts-counterproposal</loc><lastmod>2026-10-23T18:06:01+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-12_federal-council-rejects-cost-brake-initiative-and-adopts-counterproposal" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-05_federal-administrative-court-decision-c-1197-2018-from-12-october-2021</loc><lastmod>2026-10-23T18:06:02+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-05_federal-administrative-court-decision-c-1197-2018-from-12-october-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-05_review-of-medicines-2021-foph-reduces-prices</loc><lastmod>2026-10-23T18:06:03+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-05_review-of-medicines-2021-foph-reduces-prices" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-05_coronavirus-astrazeneca-withdraws-authorisation-application-for-covid-19-vaccine-in-switzerland</loc><lastmod>2026-10-23T18:06:03+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-05_coronavirus-astrazeneca-withdraws-authorisation-application-for-covid-19-vaccine-in-switzerland" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-11-05_coronavirus-federal-council-simplifies-access-to-covid-certificate-for-recovered-persons</loc><lastmod>2026-10-23T18:06:04+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-11-05_coronavirus-federal-council-simplifies-access-to-covid-certificate-for-recovered-persons" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-22_federal-supreme-court-decision-9c-612-2020-from-22-september-2021</loc><lastmod>2026-10-23T18:06:04+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-22_federal-supreme-court-decision-9c-612-2020-from-22-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-22_federal-administrative-court-decision-c-5675-2018-from-10-august-2021</loc><lastmod>2026-10-23T18:06:05+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-22_federal-administrative-court-decision-c-5675-2018-from-10-august-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-22_curevac-withdraws-authorisation-application-for-covid-19-vaccine</loc><lastmod>2026-10-23T18:06:05+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-22_curevac-withdraws-authorisation-application-for-covid-19-vaccine" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-29_federal-administrative-court-decision-c-1050-2020-of-5-october-2021</loc><lastmod>2026-10-23T18:06:06+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-29_federal-administrative-court-decision-c-1050-2020-of-5-october-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-29_european-medicines-agency-generating-high-quality-evidence-from-registry-based-studies</loc><lastmod>2026-10-23T18:06:06+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-29_european-medicines-agency-generating-high-quality-evidence-from-registry-based-studies" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-15_federal-administrative-court-c-4236-2020-of-22-december-2020</loc><lastmod>2026-10-23T18:06:07+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-15_federal-administrative-court-c-4236-2020-of-22-december-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-15_federal-administrative-court-decision-c-6113-2018-of-29-september-2021</loc><lastmod>2026-10-23T18:06:07+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-15_federal-administrative-court-decision-c-6113-2018-of-29-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-15_update-on-reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland</loc><lastmod>2026-10-23T18:06:08+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-15_update-on-reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-15_european-medicines-agency-first-in-class-medicine-to-treat-aggressive-form-of-breast-cancer</loc><lastmod>2026-10-23T18:06:08+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-15_european-medicines-agency-first-in-class-medicine-to-treat-aggressive-form-of-breast-cancer" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-08_federal-administrative-court-decision-c-5010-2019-of-24-september-2021</loc><lastmod>2026-10-23T18:06:09+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-08_federal-administrative-court-decision-c-5010-2019-of-24-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-08_federal-administrative-court-decision-c-4697-2019-of-9-august-2021</loc><lastmod>2026-10-23T18:06:09+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-08_federal-administrative-court-decision-c-4697-2019-of-9-august-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-08_federal-administrative-court-decision-c-4368-2019-of-7-september-2021</loc><lastmod>2026-10-23T18:06:10+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-08_federal-administrative-court-decision-c-4368-2019-of-7-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-08_federal-administrative-court-decision-c-1306-2019-c-2651-2019-of-21-september-2021</loc><lastmod>2026-10-23T18:06:10+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-08_federal-administrative-court-decision-c-1306-2019-c-2651-2019-of-21-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-15_federal-administrative-court-decision-c-6117-2018-of-22-september-2021</loc><lastmod>2026-10-23T18:06:13+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-15_federal-administrative-court-decision-c-6117-2018-of-22-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-15_federal-administrative-court-decision-c-6116-2018-of-22-september-2021</loc><lastmod>2026-10-23T18:06:12+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-15_federal-administrative-court-decision-c-6116-2018-of-22-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-15_federal-administrative-court-decision-c-613-2018-of-7-september-2021</loc><lastmod>2026-10-23T18:06:12+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-15_federal-administrative-court-decision-c-613-2018-of-7-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-15_federal-council-and-parliament-recommend-approving-the-covid-19-act</loc><lastmod>2026-10-23T18:06:14+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-15_federal-council-and-parliament-recommend-approving-the-covid-19-act" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-15_coronavirus-confederation-signs-agreement-with-janssen</loc><lastmod>2026-10-23T18:06:13+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-15_coronavirus-confederation-signs-agreement-with-janssen" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-15_coronavirus-federal-council-plans-new-vaccination-drive</loc><lastmod>2026-10-23T18:06:14+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-15_coronavirus-federal-council-plans-new-vaccination-drive" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-01_coronavirus-reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland---update</loc><lastmod>2026-10-23T18:06:15+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-01_coronavirus-reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland---update" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-01_federal-supreme-court-decision-2c-322-2021-of-20-august-2021</loc><lastmod>2026-10-23T18:06:15+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-01_federal-supreme-court-decision-2c-322-2021-of-20-august-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-10-01_federal-supreme-court-decision-4a-168-2021-4a-172-2021-of-6-september-2021</loc><lastmod>2026-10-23T18:06:16+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-10-01_federal-supreme-court-decision-4a-168-2021-4a-172-2021-of-6-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-24_federal-supreme-court-decision-9c-348-2021-of-26-august-2021</loc><lastmod>2026-10-23T18:06:18+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-24_federal-supreme-court-decision-9c-348-2021-of-26-august-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-24_federal-administrative-court-decision-c-4772-2019-of-6-september-2021</loc><lastmod>2026-10-23T18:06:17+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-24_federal-administrative-court-decision-c-4772-2019-of-6-september-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-24_federal-administrative-court-decision-c-5675-2018-of-10-august-2021</loc><lastmod>2026-10-23T18:06:17+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-24_federal-administrative-court-decision-c-5675-2018-of-10-august-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-24_federal-administrative-court-decision-c-2798-2020-of-27-august-2021</loc><lastmod>2026-10-23T18:06:19+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-24_federal-administrative-court-decision-c-2798-2020-of-27-august-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-24_coronavirus-new-rules-for-entry-to-switzerland-and-for-people-vaccinated-abroad-to-access-the-covid-certificate</loc><lastmod>2026-10-23T18:06:18+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-24_coronavirus-new-rules-for-entry-to-switzerland-and-for-people-vaccinated-abroad-to-access-the-covid-certificate" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-24_federal-council-adopts-dispatch-for-counter-proposal-to-the-premium-relief-initiative</loc><lastmod>2026-10-23T18:06:19+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-24_federal-council-adopts-dispatch-for-counter-proposal-to-the-premium-relief-initiative" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-10_swissmedic-information-event-on-the-new-medical-devices-regulation</loc><lastmod>2026-10-23T18:06:21+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-10_swissmedic-information-event-on-the-new-medical-devices-regulation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-10_coronavirus-federal-council-extends-covid-certificate-requirement-and-launches-consultation-on-new-entry-rules</loc><lastmod>2026-10-23T18:06:21+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-10_coronavirus-federal-council-extends-covid-certificate-requirement-and-launches-consultation-on-new-entry-rules" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-07_federal-supreme-court-decision-9c-710-2020-of-10-august-2021</loc><lastmod>2026-10-23T18:06:22+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-07_federal-supreme-court-decision-9c-710-2020-of-10-august-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-07_coronavirus-majority-positive-response-to-the-extension-of-the-certificate-obligation</loc><lastmod>2026-10-23T18:06:23+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-07_coronavirus-majority-positive-response-to-the-extension-of-the-certificate-obligation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-07_coronavirus-ecdc-and-ema-highlight-considerations-for-additional-and-booster-doses-of-covid-19-vaccines</loc><lastmod>2026-10-23T18:06:22+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-07_coronavirus-ecdc-and-ema-highlight-considerations-for-additional-and-booster-doses-of-covid-19-vaccines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-09-07_federal-council-proposes-assumption-of-costs-for-medical-products-from-abroad</loc><lastmod>2026-10-23T18:06:23+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-09-07_federal-council-proposes-assumption-of-costs-for-medical-products-from-abroad" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-08-27_federal-administrative-court-decision-c-4697-2019-of-9-august-2021-2</loc><lastmod>2026-10-23T18:06:24+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-08-27_federal-administrative-court-decision-c-4697-2019-of-9-august-2021-2" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-08-27_implementing-ordinance-for-facilitated-access-to-treatment-with-medicinal-cannabis-in-the-consultation-phase</loc><lastmod>2026-10-23T18:06:25+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-08-27_implementing-ordinance-for-facilitated-access-to-treatment-with-medicinal-cannabis-in-the-consultation-phase" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-08-20_artificial-intelligence-in-medicine-regulation</loc><lastmod>2026-10-23T18:06:25+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-08-20_artificial-intelligence-in-medicine-regulation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-08-20_federal-supreme-court-decision-2c-149-2021-of-3-august-2021</loc><lastmod>2026-10-23T18:06:26+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-08-20_federal-supreme-court-decision-2c-149-2021-of-3-august-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-08-13_new-work-sharing-initiative-from-the-access-consortium-for-assessment-of-biosimilar-applications</loc><lastmod>2026-10-23T18:06:26+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-08-13_new-work-sharing-initiative-from-the-access-consortium-for-assessment-of-biosimilar-applications" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-08-13_electronic-patient-dossier-federal-council-wants-to-promote-dissemination-and-use-in-a-targeted-manner</loc><lastmod>2026-10-23T18:06:27+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-08-13_electronic-patient-dossier-federal-council-wants-to-promote-dissemination-and-use-in-a-targeted-manner" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-08-12_federal-administrative-court-decision-c-5008-2019-of-14-july-2021</loc><lastmod>2026-10-23T18:06:28+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-08-12_federal-administrative-court-decision-c-5008-2019-of-14-july-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-08-12_interoperability-of-track-and-trace-systems-key-to-public-health-protection</loc><lastmod>2026-10-23T18:06:28+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-08-12_interoperability-of-track-and-trace-systems-key-to-public-health-protection" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-08-12_benchmarking-2021-comparison-of-swiss-approval-times-for-human-medicines-with-the-eu-and-the-usa</loc><lastmod>2026-10-23T18:06:29+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-08-12_benchmarking-2021-comparison-of-swiss-approval-times-for-human-medicines-with-the-eu-and-the-usa" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-07-16_federal-supreme-court-decision-9c-30-2020-of-14-june-2021</loc><lastmod>2026-10-23T18:06:29+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-07-16_federal-supreme-court-decision-9c-30-2020-of-14-june-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-07-09_court-of-justice-of-the-european-union-case-c-178-20-of-8-july-2021-pharma-expressz</loc><lastmod>2026-10-23T18:06:30+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-07-09_court-of-justice-of-the-european-union-case-c-178-20-of-8-july-2021-pharma-expressz" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-07-09_federal-supreme-court-decision-9c-563-2020-of-7-june-2021</loc><lastmod>2026-10-23T18:06:30+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-07-09_federal-supreme-court-decision-9c-563-2020-of-7-june-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-07-09_eu-recognises-swiss-covid-certificate</loc><lastmod>2026-10-23T18:06:31+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-07-09_eu-recognises-swiss-covid-certificate" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-07-02_federal-supreme-court-decision-2c-119-2021-of-1-june-2021</loc><lastmod>2026-10-23T18:06:32+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-07-02_federal-supreme-court-decision-2c-119-2021-of-1-june-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-07-02_federal-administrative-court-decision-c-4967-2019-of-8-june-2021</loc><lastmod>2026-10-23T18:06:33+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-07-02_federal-administrative-court-decision-c-4967-2019-of-8-june-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-07-02_kptpo-updating-of-annexes-5-6-and-8---10</loc><lastmod>2026-10-23T18:06:33+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-07-02_kptpo-updating-of-annexes-5-6-and-8---10" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-07-02_tardoc-federal-council-calls-on-tariff-partners-for-joint-revision</loc><lastmod>2026-10-23T18:06:34+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-07-02_tardoc-federal-council-calls-on-tariff-partners-for-joint-revision" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-07-02_simplified-access-to-medicines-for-acute-pain-and-migraine-at-the-pharmacy</loc><lastmod>2026-10-23T18:06:34+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-07-02_simplified-access-to-medicines-for-acute-pain-and-migraine-at-the-pharmacy" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-25_changes-in-the-ordinance-on-health-care-services-klv</loc><lastmod>2026-10-23T18:06:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-25_changes-in-the-ordinance-on-health-care-services-klv" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-25_coronavirus-impact-of-the-pandemic-on-health-costs-is-still-difficult-to-quantify</loc><lastmod>2026-10-23T18:06:35+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-25_coronavirus-impact-of-the-pandemic-on-health-costs-is-still-difficult-to-quantify" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-25_federal-council-adopts-new-admission-criteria-for-service-providers-and-standardises-hospital-planning-requirements</loc><lastmod>2026-10-23T18:06:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-25_federal-council-adopts-new-admission-criteria-for-service-providers-and-standardises-hospital-planning-requirements" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-11_federal-administrative-court-decision-c-4125-2019-of-10-march-2021</loc><lastmod>2026-10-23T18:06:37+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-11_federal-administrative-court-decision-c-4125-2019-of-10-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-11_federal-administrative-court-decision-c-3663-2017-of-31-may-2021</loc><lastmod>2026-10-23T18:06:38+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-11_federal-administrative-court-decision-c-3663-2017-of-31-may-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-11_international-regulators-and-who-address-need-to-boost-covid-19-vaccine-confidence</loc><lastmod>2026-10-23T18:06:37+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-11_international-regulators-and-who-address-need-to-boost-covid-19-vaccine-confidence" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-11_covid-19-vaccine-for-young-people-aged-12-to-17-moderna-submits-authorisation-application-to-swissmedic</loc><lastmod>2026-10-23T18:06:39+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-11_covid-19-vaccine-for-young-people-aged-12-to-17-moderna-submits-authorisation-application-to-swissmedic" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-11_swissmedic-expert-meeting-pharmacopoeia</loc><lastmod>2026-10-23T18:06:39+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-11_swissmedic-expert-meeting-pharmacopoeia" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-18_federal-administrative-court-decision-c-2410-2019-of-26-may-2021</loc><lastmod>2026-10-23T18:06:40+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-18_federal-administrative-court-decision-c-2410-2019-of-26-may-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-18_annual-report-2020-published-by-european-medicines-agency-ema</loc><lastmod>2026-10-23T18:06:41+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-18_annual-report-2020-published-by-european-medicines-agency-ema" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-18_federal-council-updates-safety-regulations-in-the-construction-industry</loc><lastmod>2026-10-23T18:06:41+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-18_federal-council-updates-safety-regulations-in-the-construction-industry" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-04_federal-administrative-court-decision-c-447-2019-of-18-may-2021</loc><lastmod>2026-10-23T18:06:43+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-04_federal-administrative-court-decision-c-447-2019-of-18-may-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-04_eu-regulators-develop-recommendations-to-forecast-demand-of-medicines</loc><lastmod>2026-10-23T18:06:42+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-04_eu-regulators-develop-recommendations-to-forecast-demand-of-medicines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-04_operation-pangea-xiv-campaign-against-counterfeit-and-illegally-imported-medicinal-products</loc><lastmod>2026-10-23T18:06:44+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-04_operation-pangea-xiv-campaign-against-counterfeit-and-illegally-imported-medicinal-products" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-04_uniform-remuneration-for-nursing-materials-implementation-regulated</loc><lastmod>2026-10-23T18:06:43+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-04_uniform-remuneration-for-nursing-materials-implementation-regulated" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-04_covid-19-federal-council-adopts-ordinance-on-covid-19-certificates</loc><lastmod>2026-10-23T18:06:44+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-04_covid-19-federal-council-adopts-ordinance-on-covid-19-certificates" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-01_first-covid-19-vaccine-approved-for-children-aged-12-to-15-in-eu</loc><lastmod>2026-10-23T18:06:45+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-01_first-covid-19-vaccine-approved-for-children-aged-12-to-15-in-eu" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-01_revised-requirements-for-combination-products-medicinal-products-with-a-medical-device-component</loc><lastmod>2026-10-23T18:06:46+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-01_revised-requirements-for-combination-products-medicinal-products-with-a-medical-device-component" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-01_coronavirus-swiss-federal-government-signs-contract-for-the-purchase-of-drugs</loc><lastmod>2026-10-23T18:06:46+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-01_coronavirus-swiss-federal-government-signs-contract-for-the-purchase-of-drugs" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-01_medical-foot-care-federal-council-improves-access-for-people-with-diabetes</loc><lastmod>2026-10-23T18:06:47+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-01_medical-foot-care-federal-council-improves-access-for-people-with-diabetes" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-06-01_national-genomic-monitoring-programme-confirmed</loc><lastmod>2026-10-23T18:06:47+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-06-01_national-genomic-monitoring-programme-confirmed" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-21_coronavirus-federal-council-decides-on-funding-programme-for-covid-19-vaccines-and-medicines</loc><lastmod>2026-10-23T18:06:48+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-21_coronavirus-federal-council-decides-on-funding-programme-for-covid-19-vaccines-and-medicines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-21_coronavirus-federal-council-specifies-use-of-the-covid-certificate</loc><lastmod>2026-10-23T18:06:48+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-21_coronavirus-federal-council-specifies-use-of-the-covid-certificate" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-21_health-insurance-stricter-regulation-of-intermediary-activities</loc><lastmod>2026-10-23T18:06:49+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-21_health-insurance-stricter-regulation-of-intermediary-activities" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-14_federal-supreme-court-decision-9c-45-2021-of-16-april-2021</loc><lastmod>2026-10-23T18:06:49+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-14_federal-supreme-court-decision-9c-45-2021-of-16-april-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-14_federal-supreme-court-decision-9c-537-2020-of-13-april-2021</loc><lastmod>2026-10-23T18:06:50+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-14_federal-supreme-court-decision-9c-537-2020-of-13-april-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-14_federal-administrative-court-decision-c-510-2019-of-15-april-2021</loc><lastmod>2026-10-23T18:06:50+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-14_federal-administrative-court-decision-c-510-2019-of-15-april-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-14_transplants-federal-council-wants-to-increase-safety</loc><lastmod>2026-10-23T18:06:51+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-14_transplants-federal-council-wants-to-increase-safety" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-14_equality-between-public-and-private-spitex-federal-council-publishes-report</loc><lastmod>2026-10-23T18:06:52+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-14_equality-between-public-and-private-spitex-federal-council-publishes-report" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-14_international-regulators-and-who-call-for-wider-public-access-to-clinical-data</loc><lastmod>2026-10-23T18:06:51+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-14_international-regulators-and-who-call-for-wider-public-access-to-clinical-data" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-07_federal-supreme-court-decision-9c-768-2020-of-13-april-2021</loc><lastmod>2026-10-23T18:06:52+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-07_federal-supreme-court-decision-9c-768-2020-of-13-april-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-07_federal-administrative-court-decision-c-573-2018-of-13-march-2021</loc><lastmod>2026-10-23T18:06:53+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-07_federal-administrative-court-decision-c-573-2018-of-13-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-06_federal-supreme-court-decision-2c-733-2020-of-15-march-2021</loc><lastmod>2026-10-23T18:06:54+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-06_federal-supreme-court-decision-2c-733-2020-of-15-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-06_federal-administrative-court-decision-c-5006-2019-of-31-march-2021</loc><lastmod>2026-10-23T18:06:54+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-06_federal-administrative-court-decision-c-5006-2019-of-31-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-06_increase-in-vaccine-manufacturing-capacity-and-supply-for-covid-19-vaccines-from-biontech-pfizer-and-moderna</loc><lastmod>2026-10-23T18:06:55+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-06_increase-in-vaccine-manufacturing-capacity-and-supply-for-covid-19-vaccines-from-biontech-pfizer-and-moderna" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-06_unpaid-health-insurance-premiums-the-federal-council-wants-to-protect-children</loc><lastmod>2026-10-23T18:06:55+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-06_unpaid-health-insurance-premiums-the-federal-council-wants-to-protect-children" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-05-06_cost-containment-in-the-health-sector-federal-council-decides-on-further-procedure</loc><lastmod>2026-10-23T18:06:56+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-05-06_cost-containment-in-the-health-sector-federal-council-decides-on-further-procedure" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-28_federal-supreme-court-decision-2c-149-2018-of-4-february-2021</loc><lastmod>2026-10-23T18:06:58+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-28_federal-supreme-court-decision-2c-149-2018-of-4-february-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-28_federal-supreme-court-decision-9c-586-2020-of-23-march-2021</loc><lastmod>2026-10-23T18:06:57+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-28_federal-supreme-court-decision-9c-586-2020-of-23-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-28_federal-administrative-court-decision-c-6365-2018-of-17-february-2021</loc><lastmod>2026-10-23T18:06:59+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-28_federal-administrative-court-decision-c-6365-2018-of-17-february-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-28_clinical-trials-information-system-reaches-major-milestone-towards-go-live-and-application-of-the-clinical-trial-regulation</loc><lastmod>2026-10-23T18:06:58+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-28_clinical-trials-information-system-reaches-major-milestone-towards-go-live-and-application-of-the-clinical-trial-regulation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-28_covid-certificate-standardised-forgery-proof-and-internationally-compatible</loc><lastmod>2026-10-23T18:06:59+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-28_covid-certificate-standardised-forgery-proof-and-internationally-compatible" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-28_coronavirus-federal-council-outlines-further-course-of-action-with-three-phase-model</loc><lastmod>2026-10-23T18:07:00+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-28_coronavirus-federal-council-outlines-further-course-of-action-with-three-phase-model" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-28_federal-government-signs-contract-for-drug-to-treat-covid-19</loc><lastmod>2026-10-23T18:07:00+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-28_federal-government-signs-contract-for-drug-to-treat-covid-19" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-16_federal-administrative-court-decision-c-400-2019-of-15-march-2021</loc><lastmod>2026-10-23T18:07:01+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-16_federal-administrative-court-decision-c-400-2019-of-15-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-16_covid-19-vaccine-janssen-assessment-of-very-rare-cases-of-unusual-blood-clots-with-low-platelets-continues</loc><lastmod>2026-10-23T18:07:01+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-16_covid-19-vaccine-janssen-assessment-of-very-rare-cases-of-unusual-blood-clots-with-low-platelets-continues" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-16_important-information-for-pharmaceutical-companies-regarding-electronic-pharmacovigilance-reporting</loc><lastmod>2026-10-23T18:07:02+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-16_important-information-for-pharmaceutical-companies-regarding-electronic-pharmacovigilance-reporting" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-16_the-federal-council-facilitates-the-voluntary-reduction-of-reserves-in-health-insurance</loc><lastmod>2026-10-23T18:07:02+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-16_the-federal-council-facilitates-the-voluntary-reduction-of-reserves-in-health-insurance" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-16_federal-office-of-public-health-publishes-2019-hospital-case-costs</loc><lastmod>2026-10-23T18:07:03+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-16_federal-office-of-public-health-publishes-2019-hospital-case-costs" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-16_more-safety-for-medical-devices-federal-council-opens-consultation-on-implementing-legislation-on-in-vitro-diagnostic</loc><lastmod>2026-10-23T18:07:03+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-16_more-safety-for-medical-devices-federal-council-opens-consultation-on-implementing-legislation-on-in-vitro-diagnostic" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-02_federal-supreme-court-decision-9c-388-2020-of-3-march-2021</loc><lastmod>2026-10-23T18:07:04+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-02_federal-supreme-court-decision-9c-388-2020-of-3-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-02_federal-administrative-court-decision-c-2827-2019-of-18-march-2021</loc><lastmod>2026-10-23T18:07:05+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-02_federal-administrative-court-decision-c-2827-2019-of-18-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-02_federal-administrative-court-decision-c-913-2019-of-3-february-2021</loc><lastmod>2026-10-23T18:07:06+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-02_federal-administrative-court-decision-c-913-2019-of-3-february-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-02_revision-of-the-list-of-means-and-objects-migel-assessment-of-the-federal-councils-statement-of-16-january-2019-report-of-the-committee-of-control-of-the-council-of-states</loc><lastmod>2026-10-23T18:07:05+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-02_revision-of-the-list-of-means-and-objects-migel-assessment-of-the-federal-councils-statement-of-16-january-2019-report-of-the-committee-of-control-of-the-council-of-states" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-02_clinical-trials-with-medical-devices-new-authorisation-practice-as-of-may-2021</loc><lastmod>2026-10-23T18:07:06+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-02_clinical-trials-with-medical-devices-new-authorisation-practice-as-of-may-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-02_swissmedic-approves-new-storage-conditions-for-the-covid-19-vaccine-from-pfizer-biontech</loc><lastmod>2026-10-23T18:07:07+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-02_swissmedic-approves-new-storage-conditions-for-the-covid-19-vaccine-from-pfizer-biontech" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-02_pilot-trials-on-controlled-dispensing-of-cannabis-can-start-in-may</loc><lastmod>2026-10-23T18:07:07+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-02_pilot-trials-on-controlled-dispensing-of-cannabis-can-start-in-may" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-09_european-court-of-human-rights-case-of-vavricka-and-others-v-the-czech-republic-of-8-april-2021</loc><lastmod>2026-10-23T18:07:08+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-09_european-court-of-human-rights-case-of-vavricka-and-others-v-the-czech-republic-of-8-april-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-09_federal-supreme-court-decision-9c-401-2020-of-5-march-2021</loc><lastmod>2026-10-23T18:07:08+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-09_federal-supreme-court-decision-9c-401-2020-of-5-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-09_federal-administrative-court-decision-c-2880-2019-of-24-march-2021</loc><lastmod>2026-10-23T18:07:09+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-09_federal-administrative-court-decision-c-2880-2019-of-24-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-09_federal-administrative-court-decision-c-3925-2019-of-30-march-2021</loc><lastmod>2026-10-23T18:07:09+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-09_federal-administrative-court-decision-c-3925-2019-of-30-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-09_astrazenecas-covid-19-vaccine-ema-finds-possible-link-to-very-rare-cases-of-unusual-blood-clots-with-low-blood-platelets</loc><lastmod>2026-10-23T18:07:10+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-09_astrazenecas-covid-19-vaccine-ema-finds-possible-link-to-very-rare-cases-of-unusual-blood-clots-with-low-blood-platelets" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-04-09_out-of-stock---covid-19---authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update-4</loc><lastmod>2026-10-23T18:07:10+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-04-09_out-of-stock---covid-19---authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update-4" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-29_federal-supreme-court-decision-9c-246-2020-of-4-march-2021</loc><lastmod>2026-10-23T18:07:11+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-29_federal-supreme-court-decision-9c-246-2020-of-4-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-29_coronavirus-ema-advises-against-use-of-ivermectin-for-the-prevention-or-treatment-of-covid-19-outside-randomised-clinical-trials</loc><lastmod>2026-10-23T18:07:12+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-29_coronavirus-ema-advises-against-use-of-ivermectin-for-the-prevention-or-treatment-of-covid-19-outside-randomised-clinical-trials" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-29_urgent-amendment-of-the-sartan-monographs-in-the-european-pharmacopoeia</loc><lastmod>2026-10-23T18:07:11+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-29_urgent-amendment-of-the-sartan-monographs-in-the-european-pharmacopoeia" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-29_new-exchange-and-information-platform-on-prevention</loc><lastmod>2026-10-23T18:07:12+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-29_new-exchange-and-information-platform-on-prevention" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-29_federal-council-approves-collective-agreement-on-diagnostic-neuropsychology-services</loc><lastmod>2026-10-23T18:07:13+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-29_federal-council-approves-collective-agreement-on-diagnostic-neuropsychology-services" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-22_federal-supreme-court-decision-2c-1028-2020-of-4-march-2021</loc><lastmod>2026-10-23T18:07:14+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-22_federal-supreme-court-decision-2c-1028-2020-of-4-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-22_federal-supreme-court-decision-2c-836-2020-of-18-february-2021</loc><lastmod>2026-10-23T18:07:13+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-22_federal-supreme-court-decision-2c-836-2020-of-18-february-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-22_coronavirus-ema-recommends-covid-19-vaccine-janssen-for-authorisation-in-the-eu</loc><lastmod>2026-10-23T18:07:14+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-22_coronavirus-ema-recommends-covid-19-vaccine-janssen-for-authorisation-in-the-eu" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-22_coronavirus-swissmedic-grants-lonza-in-visp-another-establishment-licence-for-the-production-of-covid-19-active-substances</loc><lastmod>2026-10-23T18:07:15+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-22_coronavirus-swissmedic-grants-lonza-in-visp-another-establishment-licence-for-the-production-of-covid-19-active-substances" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-22_coronavirus-consultation-on-second-phase-of-reopening-despite-precarious-situation</loc><lastmod>2026-10-23T18:07:15+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-22_coronavirus-consultation-on-second-phase-of-reopening-despite-precarious-situation" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-19_the-federal-council-improves-access-to-psychotherapy</loc><lastmod>2026-10-23T18:07:16+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-19_the-federal-council-improves-access-to-psychotherapy" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-15_federal-supreme-court-decision-9c-488-2020-of-17-february-2021</loc><lastmod>2026-10-23T18:07:16+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-15_federal-supreme-court-decision-9c-488-2020-of-17-february-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-15_federal-administrative-court-decision-c-4780-2019-of-1-march-2021</loc><lastmod>2026-10-23T18:07:17+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-15_federal-administrative-court-decision-c-4780-2019-of-1-march-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-15_coronavirus-access-consortium-statement-on-authorisations-of-modified-covid-19-vaccines-for-variants</loc><lastmod>2026-10-23T18:07:17+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-15_coronavirus-access-consortium-statement-on-authorisations-of-modified-covid-19-vaccines-for-variants" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-15_covid-19-vaccine-swiss-federal-government-signs-another-contract-with-pfizer</loc><lastmod>2026-10-23T18:07:18+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-15_covid-19-vaccine-swiss-federal-government-signs-another-contract-with-pfizer" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-15_coronavirus-ema-issues-advice-on-use-of-antibody-combination-bamlanivimab-etesevimab</loc><lastmod>2026-10-23T18:07:18+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-15_coronavirus-ema-issues-advice-on-use-of-antibody-combination-bamlanivimab-etesevimab" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-15_coronavirus-ema-starts-rolling-review-of-the-sputnik-v-covid-19-vaccine</loc><lastmod>2026-10-23T18:07:19+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-15_coronavirus-ema-starts-rolling-review-of-the-sputnik-v-covid-19-vaccine" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-05_federal-administrative-court-decision-c-7133-2017-of-16-february-2021</loc><lastmod>2026-10-23T18:07:20+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-05_federal-administrative-court-decision-c-7133-2017-of-16-february-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-05_coronavirus-ema-started-evaluating-an-application-to-extend-the-use-of-veklury-remdesivir</loc><lastmod>2026-10-23T18:07:20+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-05_coronavirus-ema-started-evaluating-an-application-to-extend-the-use-of-veklury-remdesivir" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-05_federal-administrative-court-interim-order-b-3340-2020-of-15-february-2021</loc><lastmod>2026-10-23T18:07:21+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-05_federal-administrative-court-interim-order-b-3340-2020-of-15-february-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-05_coronavirus-reports-of-delayed-local-reactions-after-vaccination</loc><lastmod>2026-10-23T18:07:21+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-05_coronavirus-reports-of-delayed-local-reactions-after-vaccination" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-05_coronavirus-ema-started-evaluating-an-application-to-extend-the-use-of-veklury-remdesivir-2</loc><lastmod>2026-10-23T18:07:22+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-05_coronavirus-ema-started-evaluating-an-application-to-extend-the-use-of-veklury-remdesivir-2" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-03-05_coronavirus-ema-issues-advice-on-use-of-regn-cov2-antibody-combination-casirivimab-imdevimab</loc><lastmod>2026-10-23T18:07:22+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-03-05_coronavirus-ema-issues-advice-on-use-of-regn-cov2-antibody-combination-casirivimab-imdevimab" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-19_federal-administrative-court-decision-c-2818-2019-of-4-february-2021</loc><lastmod>2026-10-23T18:07:23+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-19_federal-administrative-court-decision-c-2818-2019-of-4-february-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-19_federal-administrative-court-decision-c-2887-2019-of-26-january-2021</loc><lastmod>2026-10-23T18:07:23+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-19_federal-administrative-court-decision-c-2887-2019-of-26-january-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-19_federal-administrative-court-decision-b-1374-2020-of-21-december-2020</loc><lastmod>2026-10-23T18:07:24+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-19_federal-administrative-court-decision-b-1374-2020-of-21-december-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-19_swissmedic-permanently-involved-in-project-orbis</loc><lastmod>2026-10-23T18:07:24+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-19_swissmedic-permanently-involved-in-project-orbis" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-19_coronavirus-federal-council-plans-first-cautious-steps-to-reopen-from-1-march</loc><lastmod>2026-10-23T18:07:25+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-19_coronavirus-federal-council-plans-first-cautious-steps-to-reopen-from-1-march" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-16_federal-supreme-court-decision-4a-432-2020-of-16-december-2020</loc><lastmod>2026-10-23T18:07:25+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-16_federal-supreme-court-decision-4a-432-2020-of-16-december-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-16_federal-supreme-court-decision-2f-29-2020-of-22-january-2021</loc><lastmod>2026-10-23T18:07:27+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-16_federal-supreme-court-decision-2f-29-2020-of-22-january-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-16_covid-19-reports-of-suspected-adverse-reactions-to-the-covid-19-vaccines-in-switzerland</loc><lastmod>2026-10-23T18:07:26+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-16_covid-19-reports-of-suspected-adverse-reactions-to-the-covid-19-vaccines-in-switzerland" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-16_covid-19-ema-is-piloting-a-new-open-initiative</loc><lastmod>2026-10-23T18:07:26+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-16_covid-19-ema-is-piloting-a-new-open-initiative" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-05_federal-supreme-court-decision-9c-511-2020-of-13-january-2021</loc><lastmod>2026-10-23T18:07:27+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-05_federal-supreme-court-decision-9c-511-2020-of-13-january-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-05_covid-19-vaccine-ema-recommends-astrazenecas-covid-19-vaccine-for-approval-in-the-eu</loc><lastmod>2026-10-23T18:07:28+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-05_covid-19-vaccine-ema-recommends-astrazenecas-covid-19-vaccine-for-approval-in-the-eu" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-05_covid-19-vaccine-swissmedic-requests-additional-data-on-the-vaccine-from-astrazeneca</loc><lastmod>2026-10-23T18:07:28+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-05_covid-19-vaccine-swissmedic-requests-additional-data-on-the-vaccine-from-astrazeneca" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-05_covid-19-vaccine-federal-government-to-cover-vaccination-costs-for-further-groups</loc><lastmod>2026-10-23T18:07:29+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-05_covid-19-vaccine-federal-government-to-cover-vaccination-costs-for-further-groups" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-05_covid-19-vaccine-federal-government-signs-three-more-contracts</loc><lastmod>2026-10-23T18:07:29+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-05_covid-19-vaccine-federal-government-signs-three-more-contracts" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-03_european-court-of-justice-decision-c-471-18-p-of-21-january-2021</loc><lastmod>2026-10-23T18:07:30+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-03_european-court-of-justice-decision-c-471-18-p-of-21-january-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-03_federal-administrative-court-decision-c-5883-2019-and-c-5886-2019-of-12-january-2021</loc><lastmod>2026-10-23T18:07:31+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-03_federal-administrative-court-decision-c-5883-2019-and-c-5886-2019-of-12-january-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-03_recent-meetings-of-the-ich-and-the-iprp</loc><lastmod>2026-10-23T18:07:30+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-03_recent-meetings-of-the-ich-and-the-iprp" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-03_coronavirus-introduction-of-minimum-requirements-for-the-control-of-healthcare-associated-infections-in-switzerland</loc><lastmod>2026-10-23T18:07:31+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-03_coronavirus-introduction-of-minimum-requirements-for-the-control-of-healthcare-associated-infections-in-switzerland" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-02-03_coronavirus-federal-government-to-cover-costs-of-tests-for-persons-without-symptoms-and-modify-quarantine-rules</loc><lastmod>2026-10-23T18:07:32+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-02-03_coronavirus-federal-government-to-cover-costs-of-tests-for-persons-without-symptoms-and-modify-quarantine-rules" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-01-22_federal-supreme-court-decision-2c-539-2020-of-28-december-2020</loc><lastmod>2026-10-23T18:07:34+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-01-22_federal-supreme-court-decision-2c-539-2020-of-28-december-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-01-22_federal-administrative-court-decision-c-640-2018-of-6-january-2021</loc><lastmod>2026-10-23T18:07:33+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-01-22_federal-administrative-court-decision-c-640-2018-of-6-january-2021" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-01-22_federal-administrative-court-decision-c-358-2019-of-30-december-2020</loc><lastmod>2026-10-23T18:07:35+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-01-22_federal-administrative-court-decision-c-358-2019-of-30-december-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-01-22_covid-19-global-regulators-highlight-key-role-of-healthcare-professionals-in-fostering-confidence-in-covid-19-vaccines</loc><lastmod>2026-10-23T18:07:34+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-01-22_covid-19-global-regulators-highlight-key-role-of-healthcare-professionals-in-fostering-confidence-in-covid-19-vaccines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-01-22_covid-19-authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update</loc><lastmod>2026-10-23T18:07:35+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-01-22_covid-19-authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-01-15_federal-administrative-court-decision-c-4236-2020-of-22-december-2020</loc><lastmod>2026-10-23T18:07:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-01-15_federal-administrative-court-decision-c-4236-2020-of-22-december-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-01-15_coronavirus-federal-council-extends-and-tightens-measures</loc><lastmod>2026-10-23T18:07:37+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-01-15_coronavirus-federal-council-extends-and-tightens-measures" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-01-15_coronavirus-second-vaccine-approved-for-switzerland</loc><lastmod>2026-10-23T18:07:36+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-01-15_coronavirus-second-vaccine-approved-for-switzerland" /></url><url><loc>https://www.lifesciencelaw.ch/news/2021-01-15_coronavirus-ema-receives-application-for-cma-of-covid-19-vaccine-astrazeneca</loc><lastmod>2026-10-23T18:07:37+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2021-01-15_coronavirus-ema-receives-application-for-cma-of-covid-19-vaccine-astrazeneca" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-18_rutledge-v-pharmaceutical-care-management-assn-18-540-of-10-december-2020</loc><lastmod>2026-10-23T18:07:39+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-18_rutledge-v-pharmaceutical-care-management-assn-18-540-of-10-december-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-18_federal-administrative-court-decision-c-303-2019-of-2-december-2020</loc><lastmod>2026-10-23T18:07:38+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-18_federal-administrative-court-decision-c-303-2019-of-2-december-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-18_covid-19-vaccine-update-on-assessment-of-the-biontech-and-pfizer-bnt162b2-vaccine-marketing-authorisation-application</loc><lastmod>2026-10-23T18:07:38+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-18_covid-19-vaccine-update-on-assessment-of-the-biontech-and-pfizer-bnt162b2-vaccine-marketing-authorisation-application" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-18_coronavirus-federal-council-introduces-7pm-closing-time-and-closures-on-sundays-and-public-holidays</loc><lastmod>2026-10-23T18:07:40+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-18_coronavirus-federal-council-introduces-7pm-closing-time-and-closures-on-sundays-and-public-holidays" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-18_covid-19-vaccine-federal-councillor-berset-meets-with-european-health-ministers</loc><lastmod>2026-10-23T18:07:40+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-18_covid-19-vaccine-federal-councillor-berset-meets-with-european-health-ministers" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-18_covid-19-vaccine-strategy-persons-at-especially-high-risk-shall-be-vaccinated-first</loc><lastmod>2026-10-23T18:07:39+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-18_covid-19-vaccine-strategy-persons-at-especially-high-risk-shall-be-vaccinated-first" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-18_swissmedic-new-application-procedure-for-an-ftp-temporary-authorisation-of-human-medicinal-products</loc><lastmod>2026-10-23T18:07:41+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-18_swissmedic-new-application-procedure-for-an-ftp-temporary-authorisation-of-human-medicinal-products" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-18_coronavirus-authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update</loc><lastmod>2026-10-23T18:07:41+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-18_coronavirus-authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_federal-supreme-court-decision-9c-190-2020-of-13-november-2020</loc><lastmod>2026-10-23T18:07:43+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_federal-supreme-court-decision-9c-190-2020-of-13-november-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_federal-administrative-court-decision-c-3805-2018-of-12-november-2020</loc><lastmod>2026-10-23T18:07:42+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_federal-administrative-court-decision-c-3805-2018-of-12-november-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_pharmaceutical-strategy-for-europe</loc><lastmod>2026-10-23T18:07:44+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_pharmaceutical-strategy-for-europe" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_building-a-european-health-union</loc><lastmod>2026-10-23T18:07:43+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_building-a-european-health-union" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_coronavirus-european-commission-approves-contract-with-moderna</loc><lastmod>2026-10-23T18:07:44+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_coronavirus-european-commission-approves-contract-with-moderna" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_health-insurance-services</loc><lastmod>2026-10-23T18:07:45+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_health-insurance-services" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_supervisory-fee-2020---self-declaration</loc><lastmod>2026-10-23T18:07:45+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_supervisory-fee-2020---self-declaration" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_new-reporting-channels-for-adverse-reaction-reports-from-healthcare-professionals</loc><lastmod>2026-10-23T18:07:46+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_new-reporting-channels-for-adverse-reaction-reports-from-healthcare-professionals" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_swissmedic-is-examining-janssens-covid-19-vaccine</loc><lastmod>2026-10-23T18:07:46+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_swissmedic-is-examining-janssens-covid-19-vaccine" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_icmra-statement-on-the-continuation-of-clinical-trials</loc><lastmod>2026-10-23T18:07:47+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_icmra-statement-on-the-continuation-of-clinical-trials" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_the-vaccination-against-covid-19-will-be-free-for-the-population</loc><lastmod>2026-10-23T18:07:47+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_the-vaccination-against-covid-19-will-be-free-for-the-population" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_covid-19-vaccine-federal-government-secures-additional-doses-of-vaccine-from-moderna</loc><lastmod>2026-10-23T18:07:48+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_covid-19-vaccine-federal-government-secures-additional-doses-of-vaccine-from-moderna" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_covid-19-vaccine-federal-government-signs-contract-with-pfizer</loc><lastmod>2026-10-23T18:07:48+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_covid-19-vaccine-federal-government-signs-contract-with-pfizer" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-10_coronavirus-report-on-procurement-of-important-medical-goods-is-available</loc><lastmod>2026-10-23T18:07:49+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-10_coronavirus-report-on-procurement-of-important-medical-goods-is-available" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-04_ema-starts-rolling-review-of-janssens-covid-19-vaccine-ad26-cov2-s</loc><lastmod>2026-10-23T18:07:50+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-04_ema-starts-rolling-review-of-janssens-covid-19-vaccine-ad26-cov2-s" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-04_ema-receives-application-for-conditional-marketing-authorisation-of-covid-19-mrna-vaccine-bnt162b2</loc><lastmod>2026-10-23T18:07:51+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-04_ema-receives-application-for-conditional-marketing-authorisation-of-covid-19-mrna-vaccine-bnt162b2" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-04_ema-receives-application-for-conditional-marketing-authorisation-of-moderna-covid-19-vaccine</loc><lastmod>2026-10-23T18:07:50+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-04_ema-receives-application-for-conditional-marketing-authorisation-of-moderna-covid-19-vaccine" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-04_outpatient-before-inpatient-treatment-goals-achieved</loc><lastmod>2026-10-23T18:07:52+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-04_outpatient-before-inpatient-treatment-goals-achieved" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-12-04_coronavirus-the-uk-is-the-first-western-country-to-approve-a-covid-19-vaccine</loc><lastmod>2026-10-23T18:07:51+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-12-04_coronavirus-the-uk-is-the-first-western-country-to-approve-a-covid-19-vaccine" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-27_federal-administrative-court-decision-c-471-2019-of-7-october-2020</loc><lastmod>2026-10-23T18:07:52+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-27_federal-administrative-court-decision-c-471-2019-of-7-october-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-27_validity-of-gmp-certificates</loc><lastmod>2026-10-23T18:07:54+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-27_validity-of-gmp-certificates" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-27_inclusion-of-financing-of-care-in-a-unified-financing-system-for-outpatient-and-inpatient-services</loc><lastmod>2026-10-23T18:07:53+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-27_inclusion-of-financing-of-care-in-a-unified-financing-system-for-outpatient-and-inpatient-services" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-27_organ-donation-federal-council-supports-an-extended-solution-for-objections</loc><lastmod>2026-10-23T18:07:53+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-27_organ-donation-federal-council-supports-an-extended-solution-for-objections" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-27_new-hiv-diagnoses-have-decreased-slightly-in-2019</loc><lastmod>2026-10-23T18:07:54+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-27_new-hiv-diagnoses-have-decreased-slightly-in-2019" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-23_federal-administrative-court-decision-c-6120-2018-c-6094-2018-c-6119-2018-of-3-november-2020</loc><lastmod>2026-10-23T18:07:55+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-23_federal-administrative-court-decision-c-6120-2018-c-6094-2018-c-6119-2018-of-3-november-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-23_federal-administrative-court-decision-c-6592-2018-of-16-september-2020</loc><lastmod>2026-10-23T18:07:55+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-23_federal-administrative-court-decision-c-6592-2018-of-16-september-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-23_federal-administrative-court-decision-c-610-2018-of-12-october-2020</loc><lastmod>2026-10-23T18:07:56+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-23_federal-administrative-court-decision-c-610-2018-of-12-october-2020" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-23_the-european-medicines-agency-ema-published-safety-monitoring-plan-and-guidance-on-risk-management-planning-for-covid-19-vaccines</loc><lastmod>2026-10-23T18:07:56+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-23_the-european-medicines-agency-ema-published-safety-monitoring-plan-and-guidance-on-risk-management-planning-for-covid-19-vaccines" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-23_swissmedic-reviews-vaccine-candidate-from-moderna</loc><lastmod>2026-10-23T18:07:58+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-23_swissmedic-reviews-vaccine-candidate-from-moderna" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-23_list-of-means-and-objects-migel</loc><lastmod>2026-10-23T18:07:57+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-23_list-of-means-and-objects-migel" /></url><url><loc>https://www.lifesciencelaw.ch/news/2020-11-23_coronavirus-simplified-and-faster-generation-of-swisscovid-app-codes</loc><lastmod>2026-10-23T18:07:57+02:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="en" href="https://www.lifesciencelaw.ch/news/2020-11-23_coronavirus-simplified-and-faster-generation-of-swisscovid-app-codes" /></url></urlset>